Other and unspecified myopathies

G6_MYOPOTHUNS

myopathy: a disease of the muscle in which the muscle fibers do not function properly. This results in muscular weakness.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G72.8, G72.9 Hospital discharge: ICD-9 — 3594B\|359[8-9] Cause of death: ICD-10 — G72.8, G72.9 Cause of death: ICD-9 — 3594B\|359[8-9] 2 out of 7 registries used, show all original rules.	3604
4. Check minimum number of events None	3604
5. Include endpoints None	3604
6. Filter based on genotype QC (FinnGen only)	3510

Control definitions (FinnGen only)

Control exclude: G6_MYONEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_MYOPOTHUNS
CONTROL_EXCLUDE	G6_MYONEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G72[8-9]
HD_ICD_9	3594B\|359[8-9]
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G72[8-9]
COD_ICD_9	3594B\|359[8-9]
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified myopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31284	13661	17471
Only index persons	28306	12682	15624
Unadjusted period prevalence (%)
Whole population	0.44	0.39	0.49
Only index persons	0.54	0.47	0.60
Median age at first event (years)
Whole population	68.48	74.18	64.03
Only index persons	68.82	74.39	64.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3510	1458	2052
Unadjusted period prevalence (%)	0.76	0.52	0.94
Median age at first event (years)	66.12	66.14	66.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3604: Matched controls
36040

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G72.8

ICD-10 Finland

Other specified myopathies

8887.9

307.7

2627

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.5

307.7

1462

4730

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.4

307.7

646

1188

G72.9

ICD-10 Finland

Myopathy, unspecified

3158.8

307.7

1169

AA1AD

NOMESCO Finland

CT of head and brain

3.5

290.5

1693

7306

NXL00

NOMESCO Finland

Biopsy of muscle

61.2

284.1

158

T36

ICD-10 Finland

Poisoning by systemic antibiotics

7.6

254.7

383

556

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.2

246.3

458

829

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

61.3

233.8

130

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

46.8

223.3

131

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

63.6

222.7

123

N05AH04

ATC

quetiapine; oral

3.5

221.4

985

3500

L28

ICPC

Limited function/disability (L)

3.2

213.7

1139

4507

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

8.3

207.5

285

371

N05AH03

ATC

olanzapine; systemic

5.1

196.4

451

983

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.8

191.9

1647

8365

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.6

188.9

504

1241

A28

ICPC

Limited function/disability NOS

3.0

184.4

1108

4641

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.0

181.2

254

338

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.0

168.3

535

1497

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

13.4

166.4

159

124

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.9

163.8

386

856

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

162.7

755

2704

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.0

161.7

507

1403

F10.20

ICD-10 Finland

Alcohol dependence currently independent

9.1

159.6

199

229

N05AA02

ATC

levomepromazine; systemic

5.5

159.2

327

643

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.1

151.6

190

220

L89

ICD-10 Finland

Decubitus ulcer and pressure area

7.4

150.3

224

319

R53

ICD-10 Finland

Malaise and fatigue

2.6

149.6

1181

5609

M60.9

ICD-10 Finland

Myositis, unspecified

19.5

149.6

117

N03AG01

ATC

valproic acid; systemic, rectal

4.4

146.0

402

1007

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

142.8

895

3769

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

141.3

957

4193

SPAT1216

SPAT

Assessment of functional ability

2.8

139.4

916

3949

SPAT1254

SPAT

Administration of medicine

2.8

138.0

853

3559

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

137.5

1362

7146

N05BA01

ATC

diazepam; systemic, rectal

3.0

135.0

713

2729

M33.2

ICD-10 Finland

Polymyositis

41.4

134.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

133.9

588

2020

F10.24

ICD-10 Finland

Alcohol depence active use

9.4

131.5

160

178

N05AF03

ATC

chlorprothixene; systemic

6.8

131.1

211

326

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

10.7

127.6

140

135

N03AE01

ATC

clonazepam; systemic

4.1

127.4

375

985

N05AX08

ATC

risperidone; systemic

3.3

126.7

545

1845

N07BB01

ATC

disulfiram; oral

5.0

126.4

287

614

P15

ICPC

Chronic alcohol abuse

6.0

123.5

227

401

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

122.5

810

3478

SPAT1229

SPAT

Assessment of need for aid

3.3

120.0

514

1733

N05BA04

ATC

oxazepam; oral

2.4

119.8

1173

6051

N06AX11

ATC

mirtazapine; oral

2.3

119.5

1448

8179

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.9

118.8

166

219

M60.8

ICD-10 Finland

Other myositis

30.2

116.7

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.0

116.0

160

208

N05CD07

ATC

temazepam; oral

2.8

115.5

697

2847

SPAT1234

SPAT

Support of social functional capacity

3.7

112.5

384

1117

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

110.7

751

3250

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.0

110.0

331

881

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

12.5

109.9

109

N06AB04

ATC

citalopram; systemic

2.4

107.3

933

4532

SPAT1172

SPAT

Guidance concerning hydration

5.4

105.2

214

415

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

101.9

586

2323

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

15.1

101.7

C03CA01

ATC

furosemide; systemic

2.1

101.2

1537

9342

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.0

101.2

184

321

N17.8

ICD-10 Finland

Other acute renal failure

8.2

99.9

135

171

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.6

99.7

165

262

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.0

96.8

297

800

E86

ICD-10 Finland

Volume depletion

4.9

96.7

219

466

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

95.1

355

1092

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

94.7

813

3900

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

+∞

94.2

N03AX09

ATC

lamotrigine; oral

4.4

92.4

241

575

N05AH02

ATC

clozapine; systemic

7.3

91.6

137

195

N03AX16

ATC

[U] pregabalin

2.2

86.4

1003

5431

S01.0

ICD-10 Finland

Open wound of scalp

2.9

85.6

461

1756

T68

ICD-10 Finland

Hypothermia

15.3

85.4

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.3

85.3

357

1177

N99

ICPC

Neurological disease other

7.6

84.0

121

165

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.7

83.8

203

456

W19

ICD-10 Finland

Unspecified fall

2.7

83.8

516

2106

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.8

83.6

106

124

N04AA02

ATC

biperiden; systemic

6.3

83.5

143

235

G71.08

ICD-10 Finland

Other muscular dystrophy

+∞

82.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

82.5

681

3192

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.0

82.2

247

654

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

9.6

81.5

102

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

81.2

636

2909

N05CF01

ATC

zopiclone; oral

2.0

81.1

1369

8472

A04

ICPC

Weakness/tiredness general

2.4

79.4

678

3221

N06AX16

ATC

venlafaxine; oral

2.5

79.4

557

2420

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

78.7

363

1266

A46

ICD-10 Finland

Erysipelas

2.3

78.2

724

3558

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.6

78.0

151

279

F05.9

ICD-10 Finland

Delirium, unspecified

4.8

77.4

180

391

N05BA02

ATC

chlordiazepoxide; systemic

4.9

77.2

175

372

N05AX12

ATC

aripiprazole; systemic

4.6

75.8

188

430

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.1

75.3

215

548

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

75.2

286

887

N28

ICPC

Limited function/disability (N)

5.7

74.9

141

254

R1250

NOMESCO Finland

Evaluation of functional capability

5.2

74.8

158

316

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

74.6

803

4188

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.1

73.9

160

327

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

18.2

73.3

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.0

73.1

160

330

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

17.4

73.1

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

72.8

305

1004

E87.6

ICD-10 Finland

Hypokalaemia

4.0

72.2

217

574

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

71.8

1856

13061

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.6

71.4

448

1838

A06AD11

ATC

lactulose; oral

2.2

71.3

750

3868

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

71.3

225

616

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.4

71.3

143

273

N03AX12

ATC

[U] gabapentin; oral

2.2

71.2

704

3543

ZXD05

NOMESCO Finland

Urgent procedure

1.9

70.6

1220

7531

Z2446

NOMESCO Finland

Social worker

3.0

70.5

330

1159

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.8

69.9

129

228

S06.0

ICD-10 Finland

Concussion

2.5

69.0

501

2203

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.2

68.4

113

TK800

NOMESCO Finland

Hemodialysis

5.0

67.2

147

303

N06AX21

ATC

duloxetine; oral

2.5

67.0

480

2096

M62.8

ICD-10 Finland

Other specified disorders of muscle

16.2

65.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

65.0

454

1958

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

64.8

583

2812

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.5

64.7

233

697

N05AN01

ATC

lithium; oral

5.1

64.6

137

275

N05BE01

ATC

buspirone; oral

4.3

64.2

170

409

R60.0

ICD-10 Finland

Localized oedema

2.3

64.0

571

2743

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.3

63.9

168

402

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

8.4

63.4

101

S97

ICPC

Chronic ulcer skin

2.8

63.0

341

1294

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

62.4

234

718

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

61.8

443

1931

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

61.8

432

1862

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

61.7

621

3131

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

60.8

348

1359

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.7

60.3

367

1478

WX892

NOMESCO Finland

Monitored bed care

2.6

59.9

383

1581

N29

ICPC

Neurological sympt/complt other

5.0

59.6

130

267

N05AD01

ATC

haloperidol; systemic

3.7

59.4

196

553

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

59.4

387

1612

N05AB03

ATC

perphenazine; systemic, rectal

3.8

59.3

187

511

Z72.1

ICD-10 Finland

Alcohol use

6.5

58.9

153

SPAT1167

SPAT

Insertion of urinary catheter

3.4

58.5

215

651

SPAT1301

SPAT

No procedures

1.8

58.3

1228

7970

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

57.3

1110

7012

N02AA05

ATC

oxycodone; systemic

2.0

56.7

804

4588

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.7

56.5

137

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

56.2

1287

8543

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

56.1

502

2406

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

56.1

190

545

N06AB06

ATC

sertraline; oral

2.4

56.1

420

1864

G72.0

ICD-10 Finland

Drug-induced myopathy

+∞

55.3

P16

ICPC

Acute alcohol abuse

5.6

54.4

104

190

N05BA12

ATC

alprazolam; oral

2.4

54.2

422

1904

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.9

53.8

171

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

13.7

53.6

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.2

53.1

110

216

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

52.6

266

971

N06AB03

ATC

fluoxetine; oral

2.2

52.3

473

2274

N06AA09

ATC

amitriptyline; systemic

2.3

51.9

421

1933

N05AA01

ATC

chlorpromazine; systemic, rectal

5.8

51.4

168

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.1

51.3

142

353

N05AC02

ATC

thioridazine; oral

4.8

51.0

118

255

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

50.9

167

469

N06AA12

ATC

doxepin; systemic

2.9

50.7

255

928

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

50.6

1132

7412

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

50.3

365

1594

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.9

49.6

238

844

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

16.6

48.7

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.6

48.3

171

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.3

48.1

128

309

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.5

47.4

123

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

+∞

47.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

10.1

46.9

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.2

46.8

131

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

46.8

296

1211

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.8

46.7

250

940

Y94.0

ICD-10 Finland

Accident at home

4.4

46.6

117

270

Z72.2

ICD-10 Finland

Drug use

11.9

46.3

P99

ICPC

Psychological disorders other

4.1

46.3

130

327

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

7.3

46.2

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

12.6

46.1

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

45.8

222

791

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

45.6

344

1526

N06AX03

ATC

mianserin; oral

2.9

45.5

227

822

Z3226

NOMESCO Finland

Physiotherapist

1.9

45.2

705

4116

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.7

45.1

153

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

13.2

45.1

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.1

44.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

44.5

337

1498

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

44.2

618

3478

N03AX14

ATC

levetiracetam; systemic

3.6

44.1

147

417

N06AB10

ATC

escitalopram; oral

1.9

43.6

659

3806

SPAT1263

SPAT

Sampling

1.6

42.8

1468

10662

N03AF01

ATC

carbamazepine; oral, rectal

2.7

42.7

244

949

P72

ICPC

Schizophrenia

4.5

42.3

105

240

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

42.2

201

709

L99

ICPC

Musculoskeletal disease other

4.2

41.9

114

280

SPAT1240

SPAT

Therapeutic discussion

2.3

41.8

340

1557

V03AA01, ,

ATC

4.6

41.8

100

222

TAB00

NOMESCO Finland

Lumbar puncture

3.0

41.8

192

664

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

41.4

198

700

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.2

40.8

115

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.4

40.6

154

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.1

40.5

114

287

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.4

40.5

148

446

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.7

40.4

208

N05AF05

ATC

zuclopenthixol; systemic

6.4

40.2

107

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.6

40.0

138

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

39.9

268

1126

C07AB07

ATC

bisoprolol; oral

1.6

39.9

1880

14652

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.1

39.7

C07AA05

ATC

propranolol; systemic

1.8

39.7

659

3909

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.1

39.7

115

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

39.6

489

2630

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.6

39.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

39.4

829

5272

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

39.3

306

1375

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.0

39.1

184

645

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

6.4

38.8

101

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.1

38.8

111

F61.0

ICD-10 Finland

Mixed personality disorders

5.4

38.7

146

R33

ICD-10 Finland

Retention of urine

2.1

38.6

395

1982

N02AX02

ATC

tramadol; systemic, rectal

1.6

38.6

1549

11595

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

38.5

670

4028

N02BE01

ATC

paracetamol; systemic, rectal

1.9

38.4

3114

27705

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

38.4

271

1165

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.5

38.4

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.8

38.2

195

714

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

38.2

380

1887

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

7.1

38.1

3599X

ICD-9 Finland

Muscular dystrophies and other myopathies, Myopathy, unspecified

+∞

37.6

A02BC02

ATC

pantoprazole; systemic

1.6

37.4

2367

19623

N18

ICPC

Paralysis/weakness

3.7

37.4

119

327

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

37.0

211

819

P29

ICPC

Psychological sympt/compl other

2.6

36.8

221

880

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

36.8

144

453

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.9

36.6

E0000UV, ,

ATC

1.6

36.6

1382

10164

WX730

NOMESCO Finland

Conventional respirator

4.4

36.5

217

R50.9

ICD-10 Finland

Fever, unspecified

1.9

36.4

571

3320

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

36.2

623

3727

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.7

36.1

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

81.0

35.9

N06AX26

ATC

vortioxetine; oral

2.5

35.7

239

1002

R55

ICD-10 Finland

Syncope and collapse

1.9

35.7

472

2595

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

35.6

654

3988

G71.8

ICD-10 Finland

Other primary disorders of muscles

+∞

35.5

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

35.4

346

1705

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

35.2

115

322

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

35.2

281

1275

N05CF02

ATC

zolpidem; oral

1.8

34.7

592

3529

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

34.6

138

439

L19

ICPC

Muscle symptom/complaint NOS

3.4

34.6

128

389

X58

ICD-10 Finland

Exposure to other specified factors

1.9

34.5

499

2824

ZY000

NOMESCO Finland

Hospital inpatient

5.2

34.4

139

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

7.7

34.4

F31

ICD-10 Finland

Bipolar affective disorder

5.9

34.3

104

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

34.2

287

1330

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.7

34.1

108

296

F34.1

ICD-10 Finland

Dysthymia

3.2

34.0

140

454

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

9.2

33.9

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.0

33.8

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

11.0

33.8

G71.18

ICD-10 Finland

Other myotonic disease

93.5

33.8

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

11.4

33.6

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

32.9

247

1090

K08.3

ICD-10 Finland

Retained dental root

2.2

32.9

313

1525

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.4

32.7

SPAT1125

SPAT

Stoma care and guidance

3.7

32.7

104

286

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.7

32.7

104

286

E87.2

ICD-10 Finland

Acidosis

6.9

32.6

ZZA00

NOMESCO Finland

Split skin graft

3.0

32.6

147

503

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.7

32.5

187

729

A29

ICPC

General symptom/complaint other

1.9

32.3

485

2774

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

32.2

659

4130

N05AL01

ATC

sulpiride; systemic

4.5

32.2

179

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

31.9

259

1182

SPAT1265

SPAT

Breathalyser

5.6

31.9

108

P18

ICPC

Medication abuse

6.9

31.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

31.6

288

1378

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.2

31.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

31.5

363

1898

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.5

31.5

174

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

12.5

31.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

30.9

167

630

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

9.3

30.9

G72

ICD-10 Finland

Other myopathies

315.6

30.9

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

30.8

409

2246

N03AF02

ATC

oxcarbazepine; oral

3.0

30.8

142

492

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

30.6

429

2397

J01FF01

ATC

clindamycin; systemic

1.6

30.6

929

6432

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

30.2

1037

7387

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

12.1

29.9

Z08

ICPC

Social welfare problem

4.7

29.6

150

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.2

29.5

196

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

29.5

485

2848

T51.0

ICD-10 Finland

Toxic effect: Ethanol

9.8

29.4

L76

ICPC

Fracture: other

2.9

29.4

142

505

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

29.3

595

3712

F03

ICD-10 Finland

Unspecified dementia

2.3

29.3

220

971

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

29.3

390

2143

G62.8

ICD-10 Finland

Other specified polyneuropathies

5.3

29.2

110

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.9

29.1

A01

ICPC

Pain general/multiple sites

2.0

29.0

337

1767

G70.0

ICD-10 Finland

Myasthenia gravis

294.3

28.8

WX872

NOMESCO Finland

Intensive care

2.3

28.8

228

1030

F22.0

ICD-10 Finland

Delusional disorder

4.3

28.7

179

N05CD02

ATC

nitrazepam; oral

3.6

28.6

269

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

9.8

28.5

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

28.5

134

469

N30.0

ICD-10 Finland

Acute cystitis

1.8

28.5

531

3234

N07AA02

ATC

pyridostigmine; systemic

26.3

28.4

TNX05

NOMESCO Finland

Simple incision of soft tissue, unspecified region

26.3

28.4

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

28.2

317

1641

N06AA06

ATC

trimipramine; systemic

3.2

28.1

110

346

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

7.5

28.0

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.3

28.0

108

337

SPAT1262

SPAT

Handing over of treatment supplies

1.7

28.0

660

4283

X31

ICD-10 Finland

Exposure to excessive natural cold

9.5

28.0

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

27.8

191

810

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

27.8

437

2530

SPAT1211

SPAT

Application of soft bandage

2.0

27.7

329

1737

Z3231

NOMESCO Finland

Registered nurse

1.6

27.6

955

6788

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

27.6

125

429

M03BX01

ATC

baclofen; systemic

3.7

27.5

248

P03

ICPC

Feeling depressed

2.1

27.3

258

1251

SPAT1053

SPAT

Memory test

1.7

27.3

602

3835

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

27.2

195

SPAT1227

SPAT

Substance abuse rehabilitation

7.7

27.2

G72.4

ICD-10 Finland

Inflammatory myopathy, not elsewhere classified

+∞

27.1

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.0

27.0

196

R42

ICD-10 Finland

Dizziness and giddiness

1.6

26.9

807

5548

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

26.9

974

6987

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

26.9

459

2722

SPAT1139

SPAT

Nutrition survey

2.7

26.9

148

564

F20.0

ICD-10 Finland

Paranoid schizophrenia

6.4

26.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

26.8

367

2033

N06AX05

ATC

trazodone; oral

3.3

26.8

104

326

S00.0

ICD-10 Finland

Superficial injury of scalp

3.1

26.6

114

379

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

26.5

226

1052

P19

ICPC

Drug abuse

6.4

26.5

SPAT1252

SPAT

Overall medication plan or its review

2.0

26.3

285

1455

R13

ICD-10 Finland

Dysphagia

2.1

26.3

273

1372

AA1XD

NOMESCO Finland

Other special CT of head and brain

7.6

26.3

M79.6

ICD-10 Finland

Pain in limb

1.5

26.3

1326

10177

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

26.3

108

350

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

7.2

26.3

S18

ICPC

Laceration/cut

1.5

26.2

1545

12221

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

+∞

26.1

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.8

26.0

215

IGV01

NOMESCO Finland

Psychiatric network contact

6.0

26.0

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.0

26.0

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

6.1

25.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

25.9

130

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.8

25.9

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

5.6

25.7

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.9

25.7

199

G56.3

ICD-10 Finland

Lesion of radial nerve

5.5

25.5

P28

ICPC

Limited function/disability (P)

5.2

25.5

101

R5110, ,

SPAT

2.1

25.4

258

1287

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

25.3

230

1098

L04AX01

ATC

azathioprine; systemic

2.6

25.3

153

611

N02BF02

ATC

pregabalin; oral

2.2

25.2

209

962

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.4

25.1

268

M48.0

ICD-10 Finland

Spinal stenosis

1.7

25.1

478

2921

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

25.1

346

1920

R40.2

ICD-10 Finland

Coma, unspecified

4.7

25.0

126

N05AB01

ATC

dixyrazine; systemic

4.1

24.8

164

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

24.8

271

1388

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

7.8

24.7

OAB43, ,

SPAT

0.5

24.7

201

4042

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

32.3

24.6

P20

ICPC

Memory disturbance

1.7

24.5

566

3641

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.6

24.4

S70.0

ICD-10 Finland

Contusion of hip

2.4

24.4

171

732

N03AX18

ATC

lacosamide; systemic

6.4

24.3

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

24.3

156

641

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.8

24.1

J01DB01

ATC

cefalexin; oral

1.5

24.1

2765

24653

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

24.1

194

882

A08

ICPC

Swelling

2.2

24.1

207

967

WX882

NOMESCO Finland

High dependency care

2.8

24.1

121

440

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.5

24.1

134

M79.1

ICD-10 Finland

Myalgia

1.7

24.0

437

2637

ZY010

NOMESCO Finland

Hospital outpatient

2.4

23.9

165

702

JN4AD

NOMESCO Finland

Body CT examination

1.8

23.7

373

2154

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

23.7

124

460

R4120

NOMESCO Finland

Occupational therapy

2.1

23.6

241

1203

N87

ICPC

Parkinsonism

3.4

23.6

254

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

23.6

122

450

P76

ICPC

Depressive disorder

2.3

23.6

181

806

XA402

NOMESCO Finland

ENMG

3.1

23.6

320

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.2

23.5

149

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

23.5

155

645

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

23.5

290

1550

J01MA12

ATC

levofloxacin; systemic

1.6

23.4

672

4554

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

7.3

23.3

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

23.1

219

1063

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.3

23.0

187

854

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

7.1

22.9

TK810

NOMESCO Finland

Hemofiltration

6.1

22.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

22.8

845

6060

SPAT1251

SPAT

Organisation of medication

2.4

22.7

157

668

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

84.0

22.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

22.6

318

1773

R4110

NOMESCO Finland

Physiotherapy

1.5

22.6

916

6689

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

22.5

736

5134

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

22.3

121

458

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

22.3

382

2263

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

22.2

298

1638

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

22.2

202

966

N05AE04

ATC

ziprasidone; systemic

8.0

22.1

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

8.0

22.1

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

7.3

22.0

R06.0

ICD-10 Finland

Dyspnoea

1.5

22.0

932

6860

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

22.0

156

672

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

21.8

265

1408

SPAT1243

SPAT

Psychiatric/psychological examination

3.4

21.7

238

M54.5

ICD-10 Finland

Low back pain

1.5

21.7

1090

8289

F20

ICD-10 Finland

Schizophrenia

5.7

21.6

N06AB05

ATC

paroxetine; oral

2.2

21.6

185

863

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.9

21.5

343

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.8

21.5

Z31.5

ICD-10 Finland

Genetic counselling

2.5

21.5

140

580

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

21.4

435

2701

A41.8

ICD-10 Finland

Other specified sepsis

3.0

21.4

323

S22.3

ICD-10 Finland

Fracture of rib

1.9

21.3

283

1549

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.8

21.2

A02BC01

ATC

omeprazole; systemic

1.5

21.2

918

6778

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

21.2

108

396

U04

ICPC

Incontinence urine

2.1

21.1

219

1101

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

21.0

121

472

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

20.7

203

998

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.7

20.7

173

N06AG02

ATC

moclobemide; oral

2.3

20.5

153

673

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

20.4

414

2567

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

20.2

20.3

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

20.3

890

6577

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

20.3

1258

9909

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

20.3

148

645

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

20.2

108

406

C03DA01

ATC

spironolactone; oral

1.7

20.1

454

2895

D21

ICPC

Swallowing problem

3.3

19.9

226

N06AX12

ATC

bupropion; oral

2.2

19.9

180

859

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

+∞

19.8

R27.0

ICD-10 Finland

Ataxia, unspecified

6.3

19.7

N02BF01

ATC

gabapentin; oral

1.9

19.7

263

1441

K07

ICPC

Swollen ankles/oedema

2.1

19.7

194

956

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

3.1

19.7

274

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

19.6

850

6262

H02AB06

ATC

prednisolone; systemic

1.4

19.6

1558

12781

RS220, ,

NOMESCO Finland

3.9

19.5

148

SPAT1360

SPAT

Extensive global examination

1.9

19.5

251

1359

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

19.5

119

478

RS221, ,

NOMESCO Finland

3.6

19.5

176

EBA00

NOMESCO Finland

Extraction of tooth

1.4

19.4

1094

8460

UJF32

NOMESCO Finland

Coloscopy

1.5

19.3

874

6491

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.8

19.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

19.3

145

N06AA10

ATC

nortriptyline; systemic

3.1

19.1

268

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

19.1

431

2746

S01.9

ICD-10 Finland

Open wound of head, part unspecified

3.1

19.1

258

H02AB09

ATC

hydrocortisone; systemic

2.9

19.0

323

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

19.0

343

2060

P01

ICPC

Feeling anxious/nervous/tense

1.9

19.0

262

1452

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

18.9

836

6175

SPAT1260

SPAT

Consultation of another employee

1.6

18.9

573

3915

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

18.9

181

882

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

18.7

128

542

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

28.0

18.7

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

7.7

18.7

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.0

18.7

272

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

18.6

299

N05CD08

ATC

midazolam; nasal, systemic

2.7

18.6

100

377

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

18.5

333

R52.2

ICD-10 Finland

Other chronic pain

2.4

18.5

131

564

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

18.4

2153

18711

R51.80

ICD-10 Finland

Headache

1.6

18.4

432

2779

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

18.4

318

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.8

18.3

146

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

18.3

329

1973

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

6.9

18.2

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

6.0

18.2

J01MA02

ATC

ciprofloxacin; systemic

1.4

18.2

1329

10712

G40

ICD-10 Finland

Epilepsy

4.4

18.0

104

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.4

18.0

126

540

29999

ICD-8 Finland

Unspecified psychosis

6.5

17.9

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.9

17.9

295

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.3

17.8

109

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

17.8

1159

9158

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.4

17.8

182

R52.1

ICD-10 Finland

Chronic intractable pain

4.3

17.8

105

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.3

17.8

105

108

Kela drug reimbursment

Myasthenia gravis

+∞

17.7

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

17.7

168

817

L75

ICPC

Fracture: femur

3.2

17.7

228

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.9

17.6

292

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

17.5

107

430

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.5

1070

8358

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.8

17.5

137

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

17.5

106

425

F20.10

ICD-10 Finland

Raise schizophrenia continuously

6.6

17.5

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

17.4

117

492

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

7.8

17.4

G04BD12

ATC

mirabegron; oral

1.6

17.4

410

2639

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

17.4

106

426

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

17.3

184

932

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

17.3

102

403

Z03

ICPC

Housing/neighbourhood problem

4.5

17.3

M62.5

ICD-10 Finland

Muscle wasting and atrophy, not elsewhere classified

13.9

17.2

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.0

17.2

263

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

17.2

263

A07AA09

ATC

vancomycin; oral

3.3

17.2

196

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

12.6

17.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

17.1

1338

10875

AA400

NOMESCO Finland

Electroconvulsive therapy

4.9

17.1

R11

ICD-10 Finland

Nausea and vomiting

1.8

17.0

285

1673

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.5

17.0

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

17.0

251

1419

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

17.0

196

1022

N05BA09

ATC

clobazam; oral

5.9

17.0

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

7.5

17.0

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

7.2

16.9

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

16.9

392

2511

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.3

16.9

127

561

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.1

16.8

219

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.6

16.8

155

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

16.7

244

1376

G71.28

ICD-10 Finland

Other congenital myopathy

+∞

16.7

G71.0

ICD-10 Finland

Muscular dystrophy

+∞

16.7

G72.1

ICD-10 Finland

Alcoholic myopathy

+∞

16.7

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

16.6

113

478

G20

ICD-10 Finland

Parkinson disease

2.2

16.6

137

630

F20.5

ICD-10 Finland

Residual schizophrenia

5.3

16.5

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.0

16.5

248

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.2

16.5

137

632

E000001, ,

ATC

1.5

16.4

596

4221

Z2221

NOMESCO Finland

Medical doctor

1.4

16.4

837

6326

L29

ICPC

Musculoskeletal sympt/complt other

1.8

16.4

269

1571

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

16.4

215

1172

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

16.4

290

1731

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

16.4

254

1459

K92.0

ICD-10 Finland

Haematemesis

2.5

16.3

105

433

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

16.3

2178

19140

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.6

16.3

144

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

5.2

16.3

K59.0

ICD-10 Finland

Constipation

1.9

16.2

196

1039

S43.0

ICD-10 Finland

Dislocation of shoulder joint

2.2

16.2

137

637

ZXE00

NOMESCO Finland

One hour or less

1.4

16.1

1194

9596

ZYY01

NOMESCO Finland

Contact between professionals

7.1

16.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

16.1

220

N03AB02

ATC

phenytoin; systemic

3.4

16.0

165

L17

ICPC

Foot/toe symptom/complaint

1.4

16.0

877

6707

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

16.0

162

807

X57

ICD-10 Finland

Unspecified privation

2.7

16.0

331

EBA30

NOMESCO Finland

Extraction of root of tooth

1.9

15.8

208

1134

29530

ICD-8 Finland

Schizophrenia, Paranoid type

6.4

15.8

P74

ICPC

Anxiety disorder/anxiety state

2.4

15.8

110

471

R25.2

ICD-10 Finland

Cramp and spasm

2.6

15.7

345

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.7

335

2100

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

15.7

201

1086

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

15.7

254

1476

W06

ICD-10 Finland

Fall involving bed

3.9

15.7

120

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.9

15.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

15.7

414

2735

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

6.9

15.7

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

15.7

867

6638

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

15.7

234

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

15.6

376

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.5

15.6

100

412

C08CA01

ATC

amlodipine; oral

1.3

15.6

1341

11016

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

26.4

15.6

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.3

15.6

183

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

15.5

323

2013

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

15.5

341

2157

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

14.8

15.3

S06.3

ICD-10 Finland

Focal brain injury

3.2

15.3

190

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

15.3

116

515

30188

ICD-8 Finland

Personality disorders, Alia definita

5.2

15.3

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.6

15.1

133

N88

ICPC

Epilepsy

5.0

15.0

N05AD03

ATC

melperone; systemic

3.1

15.0

198

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

14.9

103

439

SPAT1127

SPAT

Enema

3.8

14.9

120

A10BH05

ATC

linagliptin; oral

1.9

14.9

195

1062

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.1

14.9

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

14.8

105

453

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

14.8

1185

9612

J01EA01

ATC

trimethoprim; systemic

1.4

14.8

779

5907

RS222, ,

NOMESCO Finland

3.4

14.8

154

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

3.3

14.8

169

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

14.7

137

661

OAA67, ,

SPAT

0.4

14.7

1964

G12.2

ICD-10 Finland

Motor neuron disease

4.5

14.7

NC2AA

NOMESCO Finland

Forearm X-ray examination

3.2

14.6

185

M33.1

ICD-10 Finland

Other dermatomyositis

21.1

14.6

H25.8

ICD-10 Finland

Other senile cataract

1.5

14.6

421

2836

A02BC05

ATC

esomeprazole; systemic

1.3

14.6

1251

10244

E000003, ,

ATC

2.1

14.6

136

657

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

+∞

14.6

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

+∞

14.6

ZXY49

NOMESCO Finland

Other health care provider

6.4

14.5

G04BD08

ATC

solifenacin; oral

1.8

14.5

239

1396

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

5.0

14.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

14.4

434

2953

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

14.3

157

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

14.3

131

628

N04BC05

ATC

pramipexole; oral

1.7

14.3

256

1531

F05.8

ICD-10 Finland

Other delirium

3.7

14.3

119

L84

ICD-10 Finland

Corns and callosities

2.2

14.3

122

570

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

14.2

779

5945

C09AA05

ATC

ramipril; oral

1.4

14.1

895

6989

NF3AA

NOMESCO Finland

Femur X-ray examination

2.5

14.1

364

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

14.1

181

980

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

6.4

14.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

14.1

378

2506

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.9

14.1

227

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.8

14.0

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

14.0

295

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

13.9

163

856

Z00.0

ICD-10 Finland

General medical examination

1.4

13.9

596

4350

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

15.8

13.9

Z72.0

ICD-10 Finland

Tobacco use

2.5

13.9

337

N03AX11

ATC

topiramate; oral

2.9

13.9

234

A99

ICPC

Disease/condition unspecnature/site

1.6

13.9

303

1911

Z43.5

ICD-10 Finland

Attention to cystostomy

4.2

13.9

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.1

13.8

181

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

5.0

13.8

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

13.8

166

UKC02

NOMESCO Finland

Cystoscopy

1.4

13.7

583

4247

M05BA04

ATC

alendronic acid; oral

1.6

13.7

305

1932

NFM10

NOMESCO Finland

Fasciotomy of thigh

13.6

13.7

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

13.7

210

1202

29599

ICD-8 Finland

Schizophrenia, Unspecified type

5.1

13.6

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

12.1

13.6

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

4.9

13.6

G71.02

ICD-10 Finland

Muscular dystrophy facioscapulohumeral

+∞

13.5

Z28

ICPC

Limited function/disability (Z)

4.5

13.5

Z29

ICPC

Social problem NOS

2.6

13.4

301

OAA80, ,

SPAT

0.3

13.4

1206

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.9

13.4

222

NBH10

NOMESCO Finland

Reduction of dislocation of humeroscapular joint, closed

4.2

13.4

RD210, ,

NOMESCO Finland

2.9

13.4

206

SPAT1310

SPAT

Counselling related to known health issue

1.4

13.3

963

7664

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

13.3

285

N06AX22

ATC

agomelatine; oral

2.8

13.3

234

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

13.3

116

547

S14.3

ICD-10 Finland

Injury of brachial plexus

6.3

13.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.3

1373

11507

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

13.3

400

K90

ICPC

Stroke/cerebrovascular accident

2.1

13.2

120

574

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

13.2

234

1396

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.2

1059

8561

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

13.2

322

R4130

NOMESCO Finland

Speech therapy

2.4

13.1

383

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

13.1

355

2357

R26.0

ICD-10 Finland

Ataxic gait

5.9

13.0

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

5.9

13.0

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.6

13.0

277

D12

ICPC

Constipation

2.1

13.0

130

646

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

13.0

442

H03AA01

ATC

levothyroxine sodium; systemic

1.4

12.9

652

4895

R52.9

ICD-10 Finland

Pain, unspecified

1.6

12.9

288

1826

B01AA03

ATC

warfarin; systemic

1.4

12.9

745

5722

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.6

12.8

114

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.5

12.8

332

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.9

12.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

12.8

381

2582

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

12.8

496

3550

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.5

12.8

339

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.1

12.7

123

603

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

12.7

401

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.6

12.6

281

Y96.9

ICD-10 Finland

Unspecified type of accident

2.7

12.6

258

XKC03

NOMESCO Finland

Water cystometry

2.2

12.6

101

460

E66.8

ICD-10 Finland

Other obesity

2.0

12.6

134

681

H53.2

ICD-10 Finland

Diplopia

2.1

12.6

113

539

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

12.6

114

546

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

11.0

12.5

R02

ICPC

Shortness of breath/dyspnoea

1.5

12.5

402

2770

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.7

12.5

107

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.7

12.5

254

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

12.5

348

2326

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.4

12.4

131

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

12.4

134

684

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.8

12.4

226

5CM18, ,

NOMESCO Finland

5.6

12.4

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

13.2

12.4

T90

ICPC

Diabetes non-insulin dependent

1.4

12.4

786

6121

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

12.4

566

4175

H02AB07

ATC

prednisone; oral

1.5

12.3

431

3020

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.9

12.3

145

763

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

11.6

12.3

ZXD35

NOMESCO Finland

Usual procedure

2.1

12.3

112

538

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.7

12.2

245

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

10.5

12.2

K56.0

ICD-10 Finland

Paralytic ileus

3.4

12.2

128

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

12.2

488

3512

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

12.2

452

3206

N19

ICD-10 Finland

Unspecified kidney failure

1.9

12.1

140

732

S09.9

ICD-10 Finland

Unspecified injury of head

2.9

12.1

196

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

4.1

12.1

B01AB05

ATC

enoxaparin; parenteral

1.3

12.1

986

7971

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

18.1

12.0

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

9.3

12.0

S20.2

ICD-10 Finland

Contusion of thorax

1.8

11.9

170

952

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

11.9

359

2438

K85

ICD-10 Finland

Acute pancreatitis

2.6

11.9

254

RS121, ,

NOMESCO Finland

4.3

11.9

183

Kela drug reimbursment

Lamotrigin and topiramate

4.0

11.9

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.8

11.9

209

NA2AD

NOMESCO Finland

Thoracic spine CT examination

4.1

11.8

A10AB05

ATC

insulin aspart; parenteral

1.6

11.8

255

1603

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.4

11.8

339

F25

ICD-10 Finland

Schizoaffective disorders

11.7

11.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

11.8

258

1628

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

11.8

367

2512

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

11.8

133

691

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

11.7

512

3741

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

10.5

11.7

NH1AD

NOMESCO Finland

Ankle and foot CT

2.5

11.7

286

R03BB04

ATC

tiotropium bromide; inhalant

1.5

11.7

358

2442

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.5

11.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

11.6

232

1430

NJ3CM

NOMESCO Finland

Extensive MRI examination of extremities with 3 Tesla magnet

65.2

11.6

D07AC01

ATC

betamethasone; topical

1.3

11.5

1088

8961

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.3

11.5

393

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

11.5

565

4213

SPAT1247

SPAT

Outpatient detoxication and monitoring

5.3

11.5

SPAT1281

SPAT

Other administrative function

1.6

11.5

241

1504

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.4

11.5

118

S51.0

ICD-10 Finland

Open wound of elbow

2.9

11.5

191

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

9.3

11.5

SPAT1104

SPAT

Monitoring of emergency patient

1.7

11.5

213

1288

G72.2

ICD-10 Finland

Myopathy due to other toxic agents

+∞

11.5

NK1AK

NOMESCO Finland

Spectroscopy of muscles

+∞

11.5

G71.12

ICD-10 Finland

Myotonia congenita

+∞

11.5

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

5.0

11.5

Z2445

NOMESCO Finland

Psychologist

2.1

11.4

104

499

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.4

11.4

A10BA02

ATC

metformin; oral

1.3

11.4

950

7689

F32

ICD-10 Finland

Depressive episode

2.0

11.4

129

670

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.2

11.4

427

S76

ICPC

Skin infection other

1.8

11.4

169

958

XA400

NOMESCO Finland

EEG

4.5

11.4

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

3.2

11.4

144

SPAT1244

SPAT

Occupational therapy

3.3

11.3

129

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.6

11.3

261

SPAT1101

SPAT

Orthostatic test

1.8

11.3

167

946

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.4

11.3

340

IFC04, ,

SPAT

15.1

11.3

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.6

11.3

238

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

3.9

11.3

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

11.3

107

522

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

11.3

166

940

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

10.6

11.2

X84

ICD-10 Finland

Intentional self-harm by unspecified means

8.9

11.2

N06AB08

ATC

fluvoxamine; oral

2.3

11.2

385

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.3

11.2

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

11.2

274

1776

G04CA02

ATC

tamsulosin; oral

1.3

11.2

891

7163

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.9

11.2

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.0

11.2

156

Z50.1

ICD-10 Finland

Other physical therapy

1.8

11.2

173

994

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.7

11.2

Y94.8

ICD-10 Finland

Other leisure activity accident

2.2

11.1

425

J01CF05

ATC

flucloxacillin; systemic

1.7

11.1

184

1078

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

11.1

189

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.0

11.1

157

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.9

11.0

147

807

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

11.0

909

7343

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.1

11.0

473

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

11.0

161

910

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.6

11.0

253

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

11.0

163

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

10.9

258

1659

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

10.9

155

868

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

10.9

127

667

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.6

10.9

225

WYA20

NOMESCO Finland

Home visit

2.4

10.9

321

F21, ,

ICPC

3.0

10.9

164

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.4

10.9

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.0

10.9

110

550

J01DA01

ATC

[U] cefalexin

1.3

10.8

1929

17164

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

10.8

158

893

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

10.8

244

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.6

10.7

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

9.6

10.7

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

3.1

10.7

144

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.9

10.7

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.5

10.7

104

F21

ICD-10 Finland

Schizotypal disorder

4.6

10.7

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

21.5

10.7

L03

ICPC

Low back symptom/complaint

1.3

10.7

758

5991

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.6

10.6

222

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

12.9

10.6

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

10.6

109

548

A10AE04

ATC

insulin glargine; parenteral

1.5

10.6

315

2133

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

5.3

10.6

E83.51

ICD-10 Finland

Hypocalcemia

3.9

10.6

XG466

NOMESCO Finland

Sleep oxymetry

2.0

10.5

104

515

SPAT1138

SPAT

Guidance concerning bowel function

2.6

10.5

229

K92.1

ICD-10 Finland

Melaena

1.7

10.5

192

1156

M54.1

ICD-10 Finland

Radiculopathy

1.9

10.5

120

626

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

10.5

206

1266

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.2

10.4

378

F32.8

ICD-10 Finland

Other depressive episodes

2.9

10.4

168

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

10.4

G04BD11

ATC

fesoterodine; oral

2.1

10.4

471

RF120, ,

NOMESCO Finland

3.0

10.4

147

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.1

10.3

142

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

16.1

10.3

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

10.3

634

4900

G24.9

ICD-10 Finland

Dystonia, unspecified

8.2

10.3

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

10.3

220

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

10.3

175

1034

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.9

10.3

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

10.3

102

507

M60.0

ICD-10 Finland

Infective myositis

23.4

10.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

10.2

216

1352

N05AF01

ATC

flupentixol; systemic

2.6

10.2

221

R06.4

ICD-10 Finland

Hyperventilation

2.8

10.2

176

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.3

10.2

306

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

13.1

10.1

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

13.1

10.1

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

10.1

325

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

10.1

183

1099

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

10.1

181

1084

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

10.1

106

537

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.3

10.1

113

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.9

10.1

L14

ICPC

Leg/thigh symptom/complaint

1.6

10.0

234

1500

S32.4

ICD-10 Finland

Fracture of acetabulum

3.5

10.0

M79.7

ICD-10 Finland

Fibromyalgia

2.2

10.0

378

L13.9

ICD-10 Finland

Bullous disorder, unspecified

4.5

10.0

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.5

10.0

259

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

4.6

10.0

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.4

10.0

104

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.9

10.0

133

731

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.3

9.9

309

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.9

9.9

151

C07AB02

ATC

metoprolol; systemic

1.3

9.9

691

5442

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.4

9.9

100

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

5.2

9.8

G93.4

ICD-10 Finland

Encephalopathy, unspecified

8.1

9.8

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

9.8

109

564

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.8

9.8

174

P98

ICPC

Psychosis NOS/other

4.4

9.8

N05AX13

ATC

paliperidone; systemic

4.9

9.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

9.8

611

4732

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

9.8

113

593

M48.9

ICD-10 Finland

Spondylopathy, unspecified

3.8

9.8

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.9

9.8

128

700

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

9.5

9.7

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.1

9.7

126

A02BC03

ATC

lansoprazole; oral

1.3

9.7

888

7253

OAB48, ,

SPAT

0.5

9.7

1801

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

9.7

194

1198

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

9.6

125

681

I50.0

ICD-10 Finland

Congestive heart failure

1.5

9.6

288

1953

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

5.3

9.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

9.6

779

6261

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

9.6

458

H02AA02

ATC

fludrocortisone; oral

3.1

9.6

122

U05

ICPC

Urination problems other

1.7

9.6

168

1001

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.9

9.6

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

3.9

9.6

Z50.5

ICD-10 Finland

Speech therapy

3.0

9.6

138

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

9.6

119

640

A86

ICD-10 Finland

Unspecified viral encephalitis

4.4

9.5

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

8.4

9.5

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

8.4

9.5

H02AB04

ATC

methylprednisolone; systemic

1.4

9.5

413

3010

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

4.6

9.5

F60.8

ICD-10 Finland

Other specific personality disorders

4.6

9.5

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

9.5

136

764

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

10.0

9.5

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

10.0

9.5

W17

ICD-10 Finland

Other fall from one level to another

1.8

9.5

127

699

C10AC01

ATC

colestyramine; oral

2.2

9.5

354

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.8

9.5

N07BA03

ATC

varenicline; oral

1.9

9.5

121

656

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.1

9.5

123

WX213

NOMESCO Finland

Lower leg blockade

3.4

9.4

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.8

9.4

172

SPAT1255

SPAT

Intravenous administration of medicine

1.6

9.4

217

1387

R35

ICD-10 Finland

Polyuria

1.6

9.4

222

1427

M72.9

ICD-10 Finland

Fibroblastic disorder, unspecified

30.1

9.4

G70.8

ICD-10 Finland

Other specified myoneural disorders

+∞

9.4

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.2

9.4

343

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

5.2

9.4

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

21.7

9.3

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

21.7

9.3

B01AF02

ATC

apixaban; oral

1.4

9.3

429

3159

M35.7

ICD-10 Finland

Hypermobility syndrome

3.5

9.3

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

9.3

1135

9602

WX722

NOMESCO Finland

PEEP

1.7

9.3

152

888

RS230, ,

NOMESCO Finland

4.0

9.3

L60.0

ICD-10 Finland

Ingrowing nail

1.8

9.3

132

740

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

6.9

9.3

E23.00

ICD-10 Finland

Panhypopituitarism

4.7

9.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

9.3

121

661

Z10.0

ICD-10 Finland

Occupational health examination

0.4

9.3

1128

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

9.2

186

1150

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

9.2

313

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.6

9.2

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

9.2

420

3089

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

9.2

606

4727

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

9.2

186

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

3.5

9.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

9.2

540

4141

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.8

9.2

158

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

9.2

186

1153

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.7

9.1

181

L04AA06

ATC

mycophenolic acid; systemic

2.5

9.1

228

R40.0

ICD-10 Finland

Somnolence

5.0

9.1

NCM10

NOMESCO Finland

Fasciotomy of forearm

11.5

9.1

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.6

9.1

Y34

ICD-10 Finland

Unspecified event, undetermined intent

4.0

9.0

IGY02, ,

SPAT

3.4

9.0

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

9.0

179

1103

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

15.6

9.0

JN4BD

NOMESCO Finland

Extensive body CT

1.5

9.0

329

2323

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

9.0

362

B37.0

ICD-10 Finland

Candidal stomatitis

3.1

8.9

117

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

8.9

217

1406

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.7

8.9

166

P80

ICPC

Personality disorder

7.4

8.9

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

4.2

8.9

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

8.9

397

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

8.8

319

IAA01, ,

SPAT

4.9

8.8

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.6

8.8

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

8.6

8.8

RS314, ,

NOMESCO Finland

10.7

8.8

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.8

8.8

R4190

NOMESCO Finland

Nutritional therapy

2.0

8.8

509

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.8

8.7

151

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

1.9

8.7

102

538

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

8.7

105

560

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

8.7

495

3775

I50

ICD-10 Finland

Heart failure

1.9

8.7

114

625

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

8.7

408

R4180

NOMESCO Finland

Podiatric therapy

2.7

8.6

169

SPAT1153

SPAT

Removal of sutures

1.3

8.6

968

8096

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

8.6

519

V18.4

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident, driver injured in traffic accident

2.7

8.6

158

N05AC01

ATC

periciazine; systemic

4.6

8.6

ZXY60

NOMESCO Finland

2-person team, nurses

4.8

8.6

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

8.5

424

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

10.0

8.5

J01CA08

ATC

pivmecillinam; oral

1.3

8.5

984

8258

R52.0

ICD-10 Finland

Acute pain

2.0

8.5

466

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

27.6

8.5

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

27.6

8.5

L03

ICD-10 Finland

Cellulitis

3.2

8.5

100

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

3.3

8.5

L16

ICPC

Ankle symptom/complaint

1.5

8.5

299

2098

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

8.4

103

551

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.7

8.4

151

906

R44.1

ICD-10 Finland

Visual hallucinations

3.9

8.4

P27

ICPC

Fear of mental disorder

2.9

8.4

127

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.5

8.4

207

P17

ICPC

Tobacco abuse

2.8

8.4

149

SPAT1312

SPAT

General health counselling

1.3

8.4

883

7327

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.5

8.4

K70.4

ICD-10 Finland

Alcoholic hepatic failure

4.5

8.4

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2437

9135

6.15

307.65

5.3

2.1

1835.84

176.88

u/l

36.76

2320

8539

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1096

1038

14.74

307.65

3.2

2.2

2054.33

321.44

ug/l

10.53

1029

977

(3023368) Bacteria identified in Blood by Culture

1807

8797

3.11

241.72

5.3

4.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

209

139

15.90

239.89

2.0

1.5

9.46

7.08

u/l

0.73

176

118

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1061

4009

3.33

215.23

5.9

1.07

1.04

mmol/l

1.68

969

3721

(3023183) Ammonium ion [Moles/volume] in Plasma

376

652

6.32

210.32

3.1

2.7

30.71

35.80

umol/l

2.21

336

585

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1148

4856

3.00

188.27

3.7

3.3

0.80

0.82

mmol/l

2.95

1046

4525

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2408

14957

2.84

186.54

10.2

6.8

1.20

1.21

mmol/l

6.30

2024

12686

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2229

13528

2.70

176.92

9.6

6.1

1.20

1.21

mmol/l

10.29

2059

12300

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1160

5213

2.81

166.88

2.2

1.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2109

12980

2.51

154.13

5.4

4.8

33.08

35.04

g/l

34.42

1916

12044

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

616

2009

3.49

153.76

4.8

3.8

5.22

5.16

kpa

0.77

583

1895

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

595

1915

3.52

151.48

4.8

3.7

1.73

1.87

mmol/l

0.36

467

1391

(3009343) pH of Capillary blood

607

1981

3.48

151.20

4.8

3.8

7.42

7.41

0.41

244

(3019309) Folate [Moles/volume] in Red Blood Cells

1215

6115

2.49

133.62

2.1

1.8

1210.51

1168.38

nmol/l

0.72

891

4591

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2286

15257

2.36

129.65

6.7

6.2

11.81

12.20

umol/l

0.54

2137

14478

(3026008) Bacteria identified in Urine by Culture

1583

9179

2.29

123.79

3.9

3.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2492

17498

2.37

121.99

8.2

4.8

6.89

6.84

mmol/l

0.36

2403

16465

(3020779) Urea [Moles/volume] in Serum or Plasma

710

2883

2.82

119.34

7.7

7.2

12.17

10.40

mmol/l

5.49

666

2731

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1868

11732

2.23

118.61

5.9

3.9

67.50

53.35

ng/l

0.72

1598

8656

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1564

9166

2.25

117.56

3.2

2.6

60.36

68.36

u/l

0.43

1432

8446

(3020191) Ethanol [Moles/volume] in Serum or Plasma

158

200

8.22

117.10

1.9

1.4

1.44

1.25

promille

0.58

133

153

(3022217) INR in Platelet poor plasma by Coagulation assay

2188

14699

2.24

116.80

18.6

17.6

1.27

1.34

inr

2.44

627

4166

(3014111) Lactate [Moles/volume] in Serum or Plasma

683

2753

2.83

116.17

9.3

6.7

1.55

1.38

mmol/l

2.72

663

2678

(3031040) Bacteria [#/volume] in Urine by Automated count

2618

18991

2.38

115.45

6.4

4.8

866.58

1970.67

e6/l

0.71

318

(3021447) Carbon dioxide [Partial pressure] in Venous blood

713

3028

2.69

109.00

5.5

3.6

5.90

5.84

kpa

0.68

679

2935

(3012544) pH of Venous blood

729

3131

2.67

108.97

5.5

3.7

7.39

7.38

—

(3002032) Base excess in Venous blood by calculation

710

3018

2.68

108.29

5.5

3.7

1.98

2.02

mmol/l

0.09

604

2520

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

399

1225

3.54

107.61

5.8

4.1

24.70

24.84

mmol/l

0.34

364

1131

(3009466) Valproate [Moles/volume] in Serum or Plasma

215

429

5.27

102.30

5.7

4.7

352.96

345.67

umol/l

0.28

186

376

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1892

12419

2.10

101.62

2.4

2.0

91.92

93.65

pmol/l

0.75

1103

6510

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2874

22286

2.43

99.66

9.6

7.5

82.23

80.05

u/l

1.48

2699

20956

(3022313) Gas panel - Capillary blood

428

1439

3.24

99.56

5.3

3.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1345

7809

2.15

99.38

2.5

2.2

3.13

3.03

mg/l

0.87

1104

6615

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

693

3027

2.60

99.28

2.5

1.8

1.78

1.53

10.41

574

2639

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

517

1963

2.91

97.15

1.9

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

113

121

9.61

95.42

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

641

2829

2.54

89.08

2.3

2.1

0.19

0.21

g/l

6.36

565

2635

(40760892) CBC W Ordered Manual Differential panel - Blood

1936

13284

1.99

86.74

7.7

6.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2587

19671

2.12

86.73

5.6

4.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

756

3666

2.34

84.96

9.6

7.1

11.13

12.02

kpa

4.92

721

3487

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

756

3667

2.34

84.90

9.6

7.1

5.19

5.09

kpa

1.36

722

3486

(3013115) Eosinophils [#/volume] in Blood

2071

14609

1.98

84.90

7.9

6.0

0.18

0.20

e9/l

2.02

1810

12705

(3021960) Folate [Moles/volume] in Serum or Plasma

1224

7187

2.06

84.88

1.8

1.6

17.90

20.11

nmol/l

5.42

1020

6096

(3003396) Base excess in Arterial blood by calculation

753

3664

2.33

83.84

9.6

7.1

1.60

1.13

mmol/l

1.76

614

2883

(3024354) Oxygen [Partial pressure] in Venous blood

580

2510

2.56

83.61

5.3

3.0

4.62

4.53

kpa

0.38

544

2428

(3006315) Basophils [#/volume] in Blood

2017

14153

1.97

83.35

7.5

5.7

0.04

e9/l

1.54

1770

12143

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

534

2231

2.64

82.70

2.0

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

360

1215

3.18

82.68

2.2

1.8

—

(3001604) Monocytes [#/volume] in Blood

2010

14113

1.96

82.60

7.4

5.7

0.64

0.61

e9/l

3.93

1764

12112

(3006504) Eosinophils/100 leukocytes in Blood

1921

13286

1.95

82.53

7.8

6.0

2.57

2.85

6.08

1780

12368

(3019069) Monocytes/100 leukocytes in Blood

1926

13359

1.95

81.74

8.4

6.3

8.65

8.85

1.73

1788

12459

(3022948) Iron [Moles/volume] in Serum or Plasma

912

4851

2.18

81.52

2.7

2.5

11.13

12.68

umol/l

8.53

806

4514

(3000991) Gas panel - Venous blood

590

2611

2.51

80.94

11.5

8.1

—

(3019198) Lymphocytes [#/volume] in Blood

2040

14499

1.94

79.68

7.7

5.8

1.83

1.90

e9/l

0.45

1807

12714

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

375

1324

3.05

79.61

2.3

1.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

1945

13679

1.92

77.62

8.0

6.1

24.71

26.87

13.20

1800

12786

(3022096) Basophils/100 leukocytes in Blood

1858

12896

1.91

76.96

7.7

6.0

0.59

0.66

6.72

1717

12001

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1478

9529

1.93

76.52

3.5

3.2

2238.89

1711.94

ng/l

2.05

1260

8221

(3007853) Bacteria identified in Skin by Aerobe culture

700

3425

2.30

76.23

2.4

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1693

11425

1.91

76.19

2.7

2.2

74.27

77.76

nmol/l

3.79

1459

10089

(3018010) Neutrophils/100 leukocytes in Blood

1913

13470

1.90

75.12

7.8

5.9

60.16

57.92

11.74

1774

12579

(3028707) Methadone [Presence] in Urine by Screen method

156

308

5.25

74.94

3.6

3.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1520

9955

1.91

74.47

3.2

3.3

2.33

2.35

mmol/l

8.59

1256

8661

(3016502) Oxygen saturation in Arterial blood

677

3301

2.29

74.15

10.2

7.4

94.69

95.49

1.81

650

3171

(3019225) pH of Specimen

631

3003

2.33

73.06

6.1

4.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

104

140

7.62

73.01

13.3

14.2

10470.96

798.59

nmol/l

0.50

135

(3004789) Transferrin [Mass/volume] in Serum or Plasma

842

4509

2.13

72.91

2.7

2.5

2.21

2.28

g/l

2.53

745

4162

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

720

3626

2.23

72.82

2.0

1.8

—

(3019060) Gas panel - Arterial blood

499

2145

2.54

72.31

6.0

4.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

395

1512

2.81

72.14

6.3

3.8

23.89

24.17

mmol/l

0.85

375

1478

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

367

1363

2.88

70.87

2.2

1.9

2.51

2.32

ug/l

0.11

292

1192

(3013650) Neutrophils [#/volume] in Blood by Automated count

2207

16449

1.88

70.68

11.7

8.8

4.76

4.23

e9/l

13.68

1950

14280

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

709

3618

2.19

69.04

2.0

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

796

4272

2.11

67.96

2.8

2.6

20.41

22.47

3.65

654

3622

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

448

1890

2.56

67.27

1.7

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

703

3611

2.18

67.15

2.9

4.1

266.38

246.35

u/l

2.41

644

3392

(3036481) Cortisol [Moles/volume] in Serum or Plasma

539

2480

2.38

67.02

2.3

2.1

358.22

372.96

nmol/l

0.84

483

2261

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1671

11552

1.83

66.76

3.4

2.8

175.84

148.93

ug/l

2.83

1477

10546

(3018418) pH of Serum or Plasma

1361

8850

1.86

66.09

5.3

4.0

7.40

0.28

317

1704

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

8.05

65.65

2.2

2.8

172.06

107.22

umol/l

0.69

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2329

17920

1.85

64.41

5.1

3.1

69.73

53.66

u/l

5.77

2135

16530

(3020630) Protein [Mass/volume] in Serum or Plasma

553

2625

2.31

63.78

2.1

2.5

64.82

66.23

g/l

3.49

479

2369

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

590

2899

2.24

62.56

2.8

2.4

14.85

7.27

ug/l

4.43

459

2522

(3027945) Reticulocytes/100 erythrocytes in Blood

699

3716

2.09

60.45

2.3

2.5

1.88

1.79

1.51

569

3258

(3026782) Osmolality of Urine

1022

6212

1.90

60.14

3.6

3.0

514.76

548.27

mosm/kgh2o

5.40

917

5332

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

119

233

5.25

57.66

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

562

2798

2.19

57.32

2.3

2.5

68.94

68.68

e9/l

0.06

419

2128

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

274

972

2.97

57.20

1.4

1.2

—

(1616796) Gas panel - Central venous blood

222

699

3.32

56.74

3.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

469

2195

2.31

55.46

1.9

2.3

—

(3003181) Sodium [Moles/volume] in Urine

192

561

3.56

55.15

1.5

1.3

53.78

63.35

mmol/l

2.24

134

449

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

146

6.37

54.32

1.1

4.45

0.11

nmol/l

0.79

(3037522) Nuclear Ab [Titer] in Serum

636

3387

2.07

54.19

1.4

1.3

465.48

544.09

titre

0.56

135

724

(3014271) Vancomycin [Susceptibility]

176

5.76

53.27

4.1

3.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

184

547

3.49

51.45

4.0

2.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

576

3019

2.08

50.99

11.3

7.9

120.56

121.17

g/l

0.28

561

2933

(3030467) Casts [#/volume] in Urine by Automated count

1248

8391

1.75

50.91

4.2

3.3

0.60

0.47

e6/l

0.86

1044

6447

(3011288) Drugs identified in Urine by Screen method

165

460

3.71

50.81

5.8

3.6

—

(3027315) Oxygen [Partial pressure] in Blood

213

708

3.13

49.71

5.0

4.8

8.52

8.42

kpa

0.30

205

694

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

352

1522

2.45

49.56

1.6

1.7

1.64

1.53

g/l

1.29

288

1289

(3000850) Epithelial cells [#/volume] in Urine

1013

6454

1.79

49.54

3.3

2.7

5.63

5.01

e6/l

0.88

944

5798

(3012501) Base excess in Blood by calculation

212

705

3.13

49.43

5.0

4.7

2.57

2.66

mmol/l

0.21

155

481

(3013290) Carbon dioxide [Partial pressure] in Blood

212

706

3.13

49.31

5.0

4.7

4.94

5.04

kpa

1.06

204

693

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1306

8955

1.72

49.26

4.3

3.2

55.04

38.25

u/l

4.99

1207

8485

(3002582) Erythrocytes [#/volume] in Urine

1333

9205

1.71

48.90

4.3

3.4

47.60

77.10

e6/l

2.10

1112

7134

(42529582) MDA5 Ab [Presence] in Serum by Line blot

8.80

47.02

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

8.80

47.02

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

8.80

47.02

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

8.80

47.02

1.1

—

(3018095) Leukocytes [#/volume] in Urine

1467

10497

1.67

46.41

4.8

3.8

114.03

116.39

e6/l

0.04

1164

7616

(3013707) Erythrocyte sedimentation rate by Westergren method

2538

20914

1.72

46.36

5.0

4.1

16.21

13.15

mm/h

14.19

2286

19216

(3010421) pH of Blood

231

837

2.88

46.26

4.9

4.4

7.42

0.09

207

750

(40767503) Oxygen content in Capillary blood by calculation

201

676

3.09

45.95

3.5

2.4

16.17

16.09

0.08

110

347

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

396

1867

2.26

45.60

9.1

7.4

24.64

24.86

mmol/l

0.44

388

1852

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

195

648

3.12

45.49

1.5

1.4

584.07

555.44

mg/l

0.15

186

609

(3016879) Cocaine [Presence] in Urine

195

649

3.12

45.37

4.1

2.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

998

6477

1.75

45.04

1.8

1.7

21756160.47

25608112.37

pmol/l

0.09

786

5307

(3000764) Benzodiazepines [Presence] in Urine

203

695

3.04

44.98

4.0

2.5

—

(36304419) Bacteria [Presence] in Urine

1188

8124

1.69

44.12

4.2

3.2

—

(3036180) Methadone [Presence] in Urine

7.13

44.06

2.1

4.0

—

(3028300) Cannabinoids [Presence] in Urine

201

702

2.97

42.99

4.1

2.5

—

(3042936) Bacteria identified in Isolate by Culture

717

4280

1.84

42.61

2.6

2.0

—

(3027008) Opiates [Presence] in Urine

200

700

2.97

42.61

4.0

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2489

20612

1.67

42.36

4.5

3.8

15.04

14.94

pmol/l

1.06

2215

18481

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

448

2285

2.10

42.15

3.8

3.9

97.12

95.72

ng/l

0.09

368

1952

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

358

1672

2.27

42.04

12.0

9.2

24.63

24.34

mmol/l

0.65

337

1615

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

177

583

3.14

41.90

1.4

1.3

4.09

3.83

mmol/l

1.82

162

542

(3044640) Blood type and Crossmatch panel - Blood

1304

9231

1.65

41.85

3.1

2.5

—

(3013512) EKG study

1255

8805

1.65

41.68

5.0

4.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

411

2038

2.15

41.59

9.6

6.8

24.61

24.46

mmol/l

0.24

398

1938

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

7.20

41.09

2.3

2.1

140.96

147.28

nmol/l

0.16

(3027273) Bicarbonate [Moles/volume] in Venous blood

345

1602

2.28

41.05

4.3

3.4

25.02

25.20

mmol/l

0.38

336

1552

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

942

6150

1.72

40.97

2.0

1.7

1.71

1.38

mg/l

1.40

737

4736

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

5.92

39.59

1.8

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

395

1975

2.12

39.02

6.0

3.1

127.24

128.25

g/l

0.36

386

1921

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3151

28172

1.94

37.89

29.4

15.7

29.56

25.97

mg/l

7.40

2882

22674

(3044290) Cell count panel - Cerebral spinal fluid

155

508

3.14

36.99

1.7

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

761

4828

1.73

36.07

2.3

2.2

29.79

30.08

0.66

731

4681

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

236

988

2.49

35.38

2.6

3.3

2.19

2.42

ratio

0.08

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

239

1016

2.45

34.66

2.6

3.4

35.96

66.87

mg/l

1.42

186

819

(3034860) Kappa light chains.free [Mass/volume] in Serum

239

1017

2.45

34.58

2.6

3.3

52.92

119.14

mg/l

0.62

185

818

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1020

7068

1.62

34.16

2.9

2.4

—

(3027944) Amphetamines [Presence] in Urine

181

684

2.73

33.41

3.7

2.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2880

25322

1.68

33.36

5.6

4.6

1.94

2.07

mu/l

1.12

2602

22855

(3005719) IgG [Mass/volume] in Serum or Plasma

392

2071

2.00

33.13

2.5

2.8

10.06

10.62

g/l

1.79

351

1885

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

152

4.88

33.00

2.7

2.5

—

(3020891) Body temperature

273

1263

2.26

32.60

6.7

4.5

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

127

5.19

31.61

15.6

10.7

0.64

0.62

mmol/l

0.24

118

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

303

1483

2.14

31.43

5.0

4.0

50.25

48.07

0.82

297

1466

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

838

5653

1.63

30.80

3.1

2.46

mmol/l

0.25

704

4935

(3024928) Oxygen saturation in Venous blood

171

656

2.69

30.65

7.0

2.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

4.86

30.64

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1747

13898

1.50

30.33

4.7

3.8

0.00

estimate

1.34

416

2796

(3008295) Osmolality of Serum or Plasma

106

311

3.48

30.26

1.4

1.3

282.60

276.91

mosm/kgh2o

1.10

225

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

156

575

2.79

30.20

1.8

1.5

13.49

27.04

e6/l

0.59

129

451

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

156

575

2.79

30.20

1.9

1.6

1818.63

838.07

e6/l

0.45

134

474

(3021601) Nitrite [Presence] in Urine by Test strip

1741

13865

1.49

29.91

6.1

5.1

0.00

estimate

0.50

406

2600

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

542

3280

1.77

29.81

3.2

2.7

9.32

umol/l

0.00

461

2882

(3009261) Glucose [Presence] in Urine by Test strip

1758

14039

1.49

29.73

4.7

3.8

0.00

estimate

1.08

393

2505

(3019550) Sodium [Moles/volume] in Serum or Plasma

3205

29277

1.86

29.50

34.6

18.4

139.21

139.60

mmol/l

10.60

3145

28488

(3021901) Oxygen saturation in Capillary blood

161

611

2.71

29.47

3.0

2.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

178

712

2.58

29.33

1.3

1.4

0.24

g/l

0.11

170

675

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

193

4.16

29.28

1.2

1.3

2.13

2.08

mmol/l

0.19

183

(3017143) Hepatitis C virus Ab [Presence] in Serum

467

2731

1.82

28.77

1.7

1.6

—

(40758558) Short blood count panel - Blood

1007

7191

1.56

28.73

8.0

6.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3205

29350

1.83

28.23

34.6

18.6

3.98

3.99

mmol/l

1.02

3146

28512

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

524

3196

1.75

27.92

5.2

3.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

216

973

2.30

27.43

1.6

246.67

306.12

titre

—

(3017732) Neutrophils [#/volume] in Blood

348

1886

1.94

27.13

5.2

3.2

5.52

5.44

e9/l

0.03

246

1476

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

177

738

2.47

26.73

1.3

1.4

1.17

g/l

0.01

167

698

(46235355) HIV 1 and 2 tests - Meaningful Use set

588

3757

1.68

26.30

1.9

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

592

3794

1.67

26.16

12.8

7.6

—

(3016018) Differential panel - Cerebral spinal fluid

252

3.55

26.09

2.0

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1670

13423

1.45

26.00

3.1

2.7

—

(3047181) Lactate [Moles/volume] in Blood

217

1002

2.24

25.97

7.8

6.2

1.59

1.31

mmol/l

2.08

187

887

(3011048) Pyruvate [Moles/volume] in Blood

40.39

25.81

1.2

1.3

78.15

115.75

umol/l

—

(3028026) IgM [Mass/volume] in Serum or Plasma

307

1622

1.98

25.75

1.8

1.9

1.17

1.40

g/l

1.42

276

1468

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

155

619

2.57

25.64

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

204

3.84

25.58

1.7

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1900

15684

1.45

25.45

3.0

2.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

863

6093

1.55

25.39

5.0

3.9

275.46

554.12

ng/l

1.08

732

5061

(3015736) pH of Urine

1429

11189

1.46

25.31

4.4

3.5

5.83

5.78

0.17

653

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

145

4.40

25.25

1.8

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

145

4.40

25.25

1.8

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

201

3.79

24.52

1.7

1.3

—

(3016038) Potassium [Moles/volume] in Urine

201

3.79

24.52

1.2

31.04

34.52

mmol/l

0.67

176

(44816559) Phosphatidylethanol [Mass/volume] in Blood

132

498

2.71

24.47

1.6

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

207

968

2.21

24.01

5.8

4.1

3.84

3.92

mmol/l

1.31

207

960

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

746

5164

1.56

23.76

3.5

2.9

1.31

1.16

e6/l

0.47

465

2963

(40761535) Cells panel - Urine sediment

420

2514

1.76

23.68

4.5

3.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

176

775

2.34

23.55

1.5

1.3

12.18

12.78

iu/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

555

3593

1.64

23.37

4.4

4.6

32.98

32.50

0.41

380

2377

(3029937) Albumin [Presence] in Urine by Test strip

1019

7560

1.49

23.36

5.2

4.2

0.00

estimate

1.28

365

2462

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

495

3118

1.68

23.17

1.8

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

175

775

2.32

23.12

2.5

3.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

200

939

2.20

22.97

1.3

1.2

0.21

0.89

u/ml

1.66

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

310

1710

1.89

22.81

14.9

10.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

230

1159

2.05

21.98

4.1

3.3

0.30

0.33

u/ml

0.99

130

670

(3021589) Normoblasts [#/volume] in Blood

1534

12400

1.41

21.78

14.8

10.0

0.00

e9/l

0.17

1273

10113

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

411

2502

1.73

21.75

5.7

3.8

1.21

1.22

mmol/l

3.04

367

2178

(3033658) Prothrombin time (PT) actual/Normal

995

7433

1.47

21.73

6.0

4.1

85.06

86.52

0.97

958

7257

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

4.05

21.63

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

170

771

2.26

21.25

1.5

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

187

883

2.18

21.18

4.0

3.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1160

2.02

20.87

1.6

2.3

9.97

10.24

g/l

0.38

187

1021

(3017181) Myelocytes/100 leukocytes in Blood

400

2455

1.71

20.50

4.0

1.01

0.93

0.29

182

891

(3002179) Metamyelocytes/100 leukocytes in Blood

371

2234

1.74

20.37

3.7

3.8

1.19

0.71

0.89

170

761

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

108

405

2.72

20.30

8.1

6.8

11.94

mg/l

0.00

381

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1235

1.97

20.29

1.6

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

1201

9387

1.42

20.25

3.6

3.2

6.74

7.58

mmol/l

8.73

975

7864

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1236

1.97

20.24

1.6

2.3

7.46

7.44

g/l

0.06

195

1108

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

252

1359

1.92

19.83

7.2

5.2

1.82

1.64

1.40

233

1276

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

127

523

2.48

19.74

1.3

1.2

4.49

7.80

u/ml

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

154

692

2.28

19.69

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

154

692

2.28

19.69

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1234

1.96

19.67

1.6

2.3

3.71

3.68

g/l

0.14

194

1106

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

195

964

2.08

19.62

1.7

2.2

36.43

37.38

g/l

1.12

154

833

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1145

1.98

19.21

1.6

2.3

3.10

2.99

g/l

0.80

180

1016

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

206

1051

2.02

19.03

1.8

2.4

0.56

1.15

g/l

1.83

163

895

(3021440) Promyelocytes/100 leukocytes in Blood

376

2323

1.69

18.75

4.1

4.0

0.06

0.10

1.09

159

759

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

6.57

18.74

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

219

1152

1.96

18.55

1.7

1.8

40.31

38.51

u/l

0.57

195

1002

(3037756) Immunofixation for Serum or Plasma

150

684

2.24

18.53

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

30.19

18.32

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

313

2.86

18.30

2.8

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

682

4873

1.49

18.19

3.8

3.1

2.46

2.02

e6/l

0.76

408

2691

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

365

2.70

18.14

1.6

1.3

—

(3025159) Blasts/100 leukocytes in Blood

356

2187

1.70

18.11

4.0

4.1

0.04

0.29

1.03

136

625

(3024522) Salmonella sp identified in Specimen by Organism specific culture

369

2.67

17.77

1.6

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

130

568

2.34

17.76

1.3

1.2

—

255.29

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

371

2.66

17.58

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

419

2711

1.62

17.40

3.1

2.5

89.24

55.82

u/l

0.26

339

2317

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

362

2.67

17.35

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

362

2.67

17.35

1.7

1.4

—

(40761536) Microorganisms panel - Urine sediment

379

2396

1.65

17.26

5.2

4.2

—

(40761511) CBC panel - Blood by Automated count

3114

29002

1.54

17.23

27.7

14.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

364

2.65

17.17

1.7

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

876

6636

1.42

17.04

4.6

3.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

678

4896

1.47

17.03

1.5

2.58

2.61

g/l

0.13

415

2935

(3006184) Hemoglobin [Mass/volume] in Capillary blood

151

715

2.16

17.02

2.7

2.2

129.34

127.64

g/l

0.33

127

520

(3037121) Protein [Mass/volume] in Urine

200

1052

1.95

16.95

3.0

3.2

0.37

0.30

g/l

0.56

435

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

2.67

16.71

4.0

3.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

145

685

2.16

16.44

1.3

1.2

35.54

42.92

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

137

640

2.19

15.99

1.3

1.2

2.23

3.81

u/ml

1.15

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

138

649

2.17

15.84

1.3

1.2

16.04

9.27

u/ml

0.22

103

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.62

15.74

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

139

3.63

15.61

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

157

781

2.06

15.57

1.4

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3175

29824

1.54

15.50

15.1

10.6

31.53

26.66

u/l

12.67

3054

28625

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.45

15.37

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1305

10699

1.34

15.29

5.2

4.1

—

(3044927) Protein electrophoresis panel - Urine

333

2.62

15.26

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2001

0.42

15.17

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

234

1346

1.79

15.00

7.3

5.2

0.90

0.88

0.44

220

1263

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

166

858

1.98

14.82

1.8

2.3

0.00

g/l

-0.00

148

780

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.75

14.70

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

147

730

2.06

14.66

1.1

1.2

72.67

97.35

titre

1.01

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.46

14.47

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

405

2.41

14.25

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

143

3.46

14.25

1.2

156.67

139.58

nmol/l

1.04

143

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

842

1.97

14.24

1.4

255.52

272.52

ug/g

0.48

506

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.62

14.22

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

172

915

1.92

14.12

1.7

2.3

0.01

0.03

g/l

1.18

154

834

(3025941) Bacteria identified in Stool by Culture

247

1469

1.73

14.10

1.3

—

(3042517) Benzodiazepines panel - Urine

14.46

14.03

2.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

162

847

1.96

14.00

1.8

2.3

0.00

g/l

-0.00

148

779

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

108

3.83

13.85

1.1

540.07

247.69

ng/l

0.28

(3017354) Segmented neutrophils/100 leukocytes in Blood

320

2.57

13.83

3.0

3.4

62.12

55.91

1.50

269

(3040151) Glucose [Moles/volume] in Capillary blood

374

2.44

13.82

4.8

7.1

6.63

7.59

mmol/l

2.65

314

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

426

2914

1.52

13.75

3.0

3.1

266.16

232.01

ng/l

0.61

388

2656

(3023410) Appearance of Cerebral spinal fluid

253

2.76

13.65

2.3

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.34

13.57

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

397

2.38

13.47

2.4

2.2

30.33

21.58

mg/l

0.56

(3039000) Anion gap in Blood

141

716

2.01

13.26

9.7

7.1

12.56

11.24

mmol/l

2.86

128

640

(3018572) Chloride [Moles/volume] in Blood

141

717

2.01

13.21

9.7

7.1

104.19

105.31

mmol/l

1.56

128

641

(21494755) Public health laboratory ask at order entry panel

1956

0.45

13.09

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

12.88

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

164

890

1.88

12.70

1.8

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

141

728

1.97

12.66

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

240

1461

1.69

12.59

2.8

3.3

4.38

4.44

pmol/l

0.38

203

1279

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

718

5505

1.38

12.51

1.3

1.2

1.41

1.64

u/ml

0.30

176

1418

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

147

3.23

12.30

1.3

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

135

698

1.97

12.09

1.7

—

(1761868) Lipid panel - Serum or Plasma

712

9066

0.73

12.06

3.4

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

186

1079

1.76

11.62

2.5

2.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

108

525

2.09

11.48

3.1

3.5

1.32

1.58

0.34

460

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

118

596

2.01

11.31

1.7

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.14

11.25

2.2

2.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.08

11.12

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

143

776

1.88

11.12

3.7

2.09

1.58

mg/l

4.56

127

704

(4035726) Immunohistochemistry procedure

360

2484

1.50

11.09

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.03

10.98

2.2

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

132

703

1.91

10.87

2.0

1.9

12.81

11.56

mg/l

0.59

125

645

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

9.59

10.73

1.4

1.1

10.90

12.27

u/l

0.12

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

270

1762

1.58

10.73

2.4

14.47

22.67

au/ml

0.89

125

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

28.10

10.72

1.1

1.0

—

mmol/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

109

3.42

10.68

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

247

1581

1.60

10.65

1.3

59.80

57.83

au/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

331

2.32

10.60

1.4

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.92

10.56

2.1

1.8

—

(3019150) Specific gravity of Urine by Refractometry

781

6213

1.33

10.48

5.2

4.2

1.02

kg/l

0.07

100

945

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

179

2.82

10.42

1.2

1.1

56.78

43.34

mg/l

0.45

151

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2822

26381

1.32

10.42

24.1

14.8

77.41

77.48

ml/min/173m2

0.05

2476

21831

(3022493) Free Hemoglobin [Mass/volume] in Plasma

126

3.20

10.40

1.1

5.2

79.25

71.66

mg/l

0.20

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.02

10.21

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1129

9465

1.28

10.18

4.1

3.8

14.35

9.36

mg/mmol

2.23

717

6090

(3012516) Albumin [Mass/volume] in Urine

1075

8966

1.28

10.08

3.4

3.2

630.54

284.93

mg/l

1.15

703

5825

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

464

2.08

10.02

1.6

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3240

31009

1.44

9.86

42.1

23.0

38.63

40.12

13.25

3008

28775

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

474

2.05

9.84

1.3

1.2

28.19

50.18

u/ml

0.89

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

531

1.99

9.72

1.6

1.7

—

(3024731) MCV [Entitic volume]

3241

31038

1.44

9.65

41.4

22.8

92.11

91.27

18.50

3190

30490

(3010813) Leukocytes [#/volume] in Blood

3241

31045

1.44

9.57

41.6

22.9

7.43

6.84

e9/l

20.96

3171

30022

(3000963) Hemoglobin [Mass/volume] in Blood

3241

31045

1.44

9.57

41.9

23.0

128.97

135.18

g/l

79.66

3187

30504

(3007461) Platelets [#/volume] in Blood

3239

31025

1.43

9.54

41.5

22.9

243.99

243.86

e9/l

0.04

3167

30122

(3035941) MCH [Entitic mass]

3240

31037

1.43

9.53

41.3

22.7

30.49

30.39

2.25

3189

30489

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

9.09

9.50

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

3240

31040

1.43

9.50

41.5

22.8

4.27

4.48

e12/l

76.06

3166

30025

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1292

0.43

9.46

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

311

2.28

9.37

1.8

1.6

—

(3000494) Fungus identified in Specimen by Culture

446

3307

1.40

9.32

1.6

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

163

2.78

9.22

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

509

1.97

9.10

1.3

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

401

2.10

9.04

1.7

0.60

0.89

g/l

2.08

303

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

292

2.28

8.94

1.2

1.1

—

(3000012) Reticulocyte production index

478

1.99

8.92

1.6

2.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

106

563

1.91

8.87

3.7

58.71

58.18

0.16

106

563

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

427

2.04

8.73

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

475

1.98

8.72

1.5

30.63

31.30

g/l

0.20

428

(40768797) Stomach Pathology biopsy report

504

3852

1.36

8.72

1.4

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

330

2.17

8.56

2.0

2.3

1.31

1.59

g/24h

0.39

166

(3026493) Urate [Moles/volume] in Serum or Plasma

938

7830

1.27

8.47

2.9

2.8

3655.13

5499.12

umol/l

0.80

770

6776

(3004616) Nuclear Ab [Presence] in Serum

325

2.18

8.46

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

206

2.50

8.46

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

111

3.08

8.39

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

166

2.67

8.37

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

288

2.24

8.35

1.9

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

128

2.91

8.27

2.2

104.16

96.00

0.50

122

(3026389) Candida sp identified in Specimen by Organism specific culture

342

2.13

8.23

1.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

234

2.37

8.17

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2775

26125

1.27

8.14

6.9

6.1

40.73

40.47

mmol/mol

0.64

2469

23952

(3024869) Neuronal Ab [Presence] in Serum

4.37

8.14

1.2

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

101

545

1.88

8.09

3.6

3.4

4.43

4.29

e9/l

0.24

101

545

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

105

575

1.85

8.03

1.7

1.8

5.96

4.45

iu/l

0.37

193

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

126

730

1.75

8.00

1.4

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

450

1.96

7.91

1.3

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.24

7.79

1.2

1.1

1578.28

1435.03

miu/ml

0.24

(3041096) Erythrocytes [Presence] in Urine by Automated

884

7392

1.26

7.76

4.4

3.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

106

3.04

7.73

3.0

2.8

28.22

29.57

umol/l

0.20

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

426

1.97

7.72

1.3

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

299

2.16

7.65

3.3

3.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

122

710

1.74

7.64

1.3

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.52

7.64

2.9

2.2

15.05

16.86

umol/l

0.33

(3021879) Hepatitis B virus core Ab [Presence] in Serum

254

1766

1.47

7.55

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

136

2.74

7.43

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

350

2.05

7.40

1.4

1.7

—

(4200892) Spirometry reversibility

276

1972

1.43

7.11

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

476

1.87

7.04

1.3

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

399

1.95

7.01

1.3

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.98

6.99

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

252

2.20

6.94

1.4

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

7.53

6.89

5.6

8.0

—

(3012441) Differential panel - Pleural fluid

353

2.00

6.89

1.4

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

125

2.74

6.85

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

180

2.41

6.68

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

180

2.41

6.68

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

180

2.41

6.68

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

485

1.83

6.66

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

485

1.83

6.66

1.7

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

428

1.89

6.64

1.5

1.4

19720.84

1814.17

e6/l

0.96

317

(3021387) Prolactin [Units/volume] in Serum or Plasma

109

641

1.72

6.63

1.9

1.6

339.54

288.91

mu/l

0.56

590

(3016330) Potassium [Moles/time] in 24 hour Urine

6.42

6.63

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

258

2.15

6.56

1.1

—

(3011985) Renin [Units/volume] in Plasma

347

1.98

6.49

1.3

1.4

56.80

66.27

mu/l

0.16

303

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.37

6.46

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.37

6.46

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.37

6.46

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

486

1.81

6.32

4.1

3.3

—

(3045414) Leukocytes [Presence] in Urine

187

1270

1.50

6.28

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

114

2.73

6.27

3.5

2.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

2.47

6.26

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

2.47

6.26

1.1

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

133

838

1.61

6.24

5.2

2.6

3.58

3.60

g/l

0.03

127

796

(40768806) Pleura Pathology biopsy report

360

1.93

6.20

1.7

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.03

6.06

1.1

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

242

2.12

5.95

1.4

1.3

2.93

3.02

g/l

0.13

168

(3028308) Erythrocytes [#/volume] in Pleural fluid

387

1.88

5.94

1.4

38361.08

74959.24

e6/l

0.87

236

(3000093) Morphology [Interpretation] in Blood Narrative

297

2.00

5.89

1.3

1.1

—

(3017509) Phencyclidine [Presence] in Urine

6.38

5.85

2.7

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.87

5.77

1.2

1.3

10.03

418.59

ug/l

0.75

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.87

5.77

2.0

4.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

232

2.13

5.76

1.2

1.5

25.10

26.52

u/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

406

1.84

5.74

1.3

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

444

1.80

5.67

3.1

2.9

901.71

1924.34

u/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

111

687

1.64

5.63

1.7

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

164

2.33

5.58

2.3

1.7

1.79

2.33

u/field

0.37

120

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

381

1.85

5.57

1.1

1.59

1.53

g/l

0.54

339

(3024139) IgG subclass 3 [Mass/volume] in Serum

242

2.08

5.56

1.4

1.3

0.36

0.42

g/l

0.62

166

(3027135) IgG subclass 1 [Mass/volume] in Serum

242

2.08

5.56

1.4

1.3

6.29

6.88

g/l

0.71

167

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2853

27265

1.22

5.55

5.3

4.7

6.14

6.04

mmol/l

3.36

2507

24523

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

325

1.92

5.53

1.2

1.4

274.15

316.14

pmol/l

0.63

278

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.37

5.53

1.1

1.2

—

(4062490) Immunoglobulin typing, IgG

243

2.07

5.51

1.4

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.63

5.48

1.7

115.05

136.94

ng/l

0.38

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

309

2353

1.34

5.46

3.5

2.7

58.44

63.36

ml/min/173m2

1.23

143

987

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

16.04

5.41

1.9

2.2

27.74

32.20

umol/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

466

1.76

5.39

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

481

1.74

5.39

2.3

2.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.62

5.36

1.0

1.2

—

(40768443) Skin Pathology biopsy report

178

1238

1.46

5.36

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

322

1.91

5.35

1.5

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

301

1.94

5.34

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

373

1.84

5.30

1.3

0.51

0.33

nmol/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.72

5.29

2.4

2.6

0.50

0.53

u/field

0.05

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.72

5.29

1.3

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

11.27

5.29

1.6

1.0

1.89

2.50

—

(3007463) Buprenorphine [Presence] in Urine

11.27

5.29

12.6

4.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

2.49

5.28

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

568

1.67

5.26

6.4

5.7

496.94

617.88

iu/ml

0.12

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

326

1.89

5.17

1.3

—

nmol/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

400

1.79

5.09

1.6

2.1

32.49

32.65

0.10

395

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.76

5.08

1.4

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

335

1.87

5.08

1.5

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

335

1.87

5.08

1.5

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

134

2.40

5.04

2.4

49.13

50.27

umol/l

0.07

113

(3028433) Virus identified in Specimen by Culture

2.70

5.00

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

531

1.67

4.97

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

6.02

4.90

1.4

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

473

1.71

4.87

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

256

1.97

4.82

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

256

1.97

4.82

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

256

1.97

4.82

1.8

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

223

2.03

4.75

1.4

1.3

21.50

24.64

u/l

0.27

181

(3009214) Lutropin [Units/volume] in Serum or Plasma

100

632

1.60

4.72

1.6

1.4

8.75

8.46

u/l

0.07

519

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.85

4.65

1.1

—

(36660697) Celiac disease serology panel - Serum

259

1971

1.34

4.63

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

443

1.71

4.61

2.4

2.8

—

(3052592) Norovirus Ag [Presence] in Stool

2.91

4.60

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

247

1.96

4.58

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

662

0.46

4.57

1.6

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

114

749

1.54

4.57

3.1

3.2

0.91

0.84

nmol/l

0.39

569

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.53

4.55

1.7

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

372

2982

1.28

4.54

2.3

164.16

163.98

ug/g

0.00

290

2349

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

200

2.06

4.53

1.0

303.35

310.04

ng/l

0.06

128

(3005322) IgE [Units/volume] in Serum or Plasma

201

1479

1.38

4.47

1.4

1.3

318.07

229.26

u/ml

0.61

182

1357

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

202

2.04

4.42

1.0

40.24

43.63

ng/l

0.23

126

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

202

2.04

4.42

1.0

507.13

679.60

ng/l

1.37

126

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

224

1.98

4.35

1.1

1.2

110.00

173.75

titre

—

(3019977) pH of Arterial blood

190

2.06

4.34

2.6

2.5

7.40

7.43

0.79

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

218

1.98

4.30

1.9

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

437

1.68

4.29

2.1

2.2

833.55

3211.97

u/l

1.35

171

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.79

4.28

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

139

2.24

4.24

1.2

1.1

1.33

1.20

u/l

0.15

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

509

1.63

4.21

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

179

2.08

4.20

1.5

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

179

2.08

4.20

2.4

2.5

535.69

547.99

e6/l

0.06

151

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

194

2.02

4.12

1.9

2.1

18.34

18.64

nmol/l

0.06

180

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

4.09

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

280

1.83

4.05

1.2

1.1

68.43

73.33

u/l

0.12

252

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.76

4.01

1.3

1.0

363.88

293.94

pmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

114

773

1.49

3.98

1.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

341

1.74

3.96

1.3

—

(3012565) Volume of 24 hour Urine

144

2.16

3.92

2.0

2.6

2737.69

2017.11

0.90

125

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

212

1.94

3.91

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

474

1.62

3.85

1.4

97.33

120.41

u/ml

1.18

(37021550) Renin [Units/volume] in Plasma --upright

2.78

3.85

1.3

45.75

74.88

mu/l

—

(3003338) MCHC [Mass/volume]

2217

23313

0.87

3.79

36.9

20.3

330.73

332.41

g/l

12.73

2184

23080

(3043410) Blood group antigens tested for on Red Blood Cells

2.48

3.79

2.4

1.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

947

0.60

3.76

2.0

1.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.02

3.76

1.0

1.50

1.00

u/field

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

212

1620

1.33

3.74

2.4

2.5

—

(3017569) Oxygen content in Arterial blood

161

2.06

3.70

1.5

2.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

168

2.03

3.69

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.83

3.68

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.70

3.65

2.1

1.3

—

(40768446) Kidney Pathology biopsy report

110

2.28

3.61

1.6

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

170

2.01

3.58

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.75

3.58

1.1

1.5

0.50

0.34

ug/l

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

383

1.66

3.56

1.5

1.7

17.84

25.40

ug/l

1.06

377

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.62

3.49

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.88

3.48

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

104

714

1.47

3.47

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.35

3.40

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

127

911

1.41

3.36

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

452

1.58

3.36

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

110

771

1.44

3.31

3.8

2.6

214.67

196.89

0.98

103

734

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

607

1.50

3.29

1.3

1.8

0.81

0.82

nmol/l

0.04

499

(3051651) Icteric interference index of Serum or Plasma

169

1.96

3.28

3.3

3.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

114

806

1.43

3.28

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

479

1.56

3.27

1.3

1.2

332.29

270.27

u/ml

0.86

291

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.54

3.19

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

197

1528

1.31

3.17

1.7

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

115

820

1.42

3.17

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

281

1.72

3.15

2.2

2.1

1.63

2.05

u/field

0.28

102

(3014765) Yersinia sp identified in Stool by Organism specific culture

114

813

1.42

3.14

1.2

1.1

—

(4146454) Self-monitoring of blood glucose

343

1.64

3.12

2.4

2.6

—

(3017704) Immunofixation for Urine

187

1.88

3.10

1.7

1.5

—

(3047189) Immunofixation for 24 hour Urine

152

1.98

3.09

1.5

1.6

—

(3010503) CD19 cells [#/volume] in Blood

166

1.94

3.09

2.5

2.3

0.15

0.17

e9/l

0.16

160

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

112

799

1.41

3.08

1.6

0.20

8.09

iu/ml

0.57

169

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

202

1.84

3.07

1.1

1.5

16.15

14.23

umol/l

0.52

189

(3036489) Thrombin time

142

1056

1.36

3.06

2.9

2.2

22.27

21.65

0.66

130

948

(3017315) Amylase [Enzymatic activity/volume] in Urine

139

2.02

3.05

1.1

1.2

616.91

388.18

u/l

0.25

127

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

181

1.89

3.04

1.8

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

611

1.47

3.01

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

107

2.16

2.96

1.1

1.3

147.48

177.56

mmol/24h

0.76

107

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

115

831

1.40

2.96

1.3

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

177

1.87

2.90

1.5

8.92

6.74

u/l

0.21

146

(3000475) Leukocytes [#/volume] in Synovial fluid

103

733

1.42

2.90

1.5

1.6

16837.72

15311.31

e6/l

0.14

527

(3011648) Oxygen content in Venous blood

236

1.75

2.88

4.1

1.8

11.34

11.29

0.03

236

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.10

2.88

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

5.39

2.87

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.16

2.84

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.23

2.79

1.2

1.5

15.10

15.63

pmol/l

0.13

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

142

1859

0.75

2.78

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.17

2.76

1.2

1.0

—

(3045788) Cell count panel - Pleural fluid

339

1.60

2.76

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

484

1.50

2.73

1.4

1.9

3.69

4.96

mmol/24h

2.80

413

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

6.01

2.70

1.7

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.01

2.69

1.5

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

161

1.87

2.66

1.2

24.38

16.81

u/l

0.88

134

(3002385) Erythrocyte distribution width [Ratio]

2475

23842

1.12

2.62

31.8

18.6

15.75

15.09

5.97

2433

23367

(3023323) Follitropin [Units/volume] in Serum or Plasma

640

1.42

2.58

1.6

1.4

18.13

27.86

iu/l

2.57

536

(3051593) INR in Capillary blood by Coagulation assay

163

1.85

2.57

4.0

14.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

230

1.70

2.55

1.7

1.5

0.22

0.25

nmol/l

0.37

181

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.15

2.55

1.8

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

617

1.42

2.54

1.4

1.3

—

(3044941) Cell count panel - Synovial fluid

485

1.47

2.52

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.23

2.51

1.7

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

397

1.52

2.48

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

182

1451

1.27

2.44

1.2

116.88

150.16

iu/ml

0.41

507

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.40

5.2

5.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

212

1.71

2.39

1.1

1.3

—

titre

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

6.26

2.37

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.42

2.36

1.4

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.83

2.34

1.0

1.1

—

(3022145) Colonoscopy Study observation

356

3061

1.18

2.28

1.5

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.95

2.28

1.2

1.0

—

(3044889) 12 lead EKG panel

2104

20176

1.10

2.22

4.6

4.0

—

(40757373) Influenza virus identified in Isolate

2.10

2.22

1.2

1.6

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.86

2.20

1.0

1.1

105.50

100.29

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

207

1697

1.23

2.20

1.9

1.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

288

1.57

2.19

1.1

—

2.63

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

337

1.52

2.16

3.0

3.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

487

4310

1.15

2.16

1.3

1.2

32.67

36.26

iu/ml

0.15

153

1369

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.29

2.15

1.3

1.1

22.72

15.65

nmol/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.78

2.13

1.2

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

152

1.78

2.11

2.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

152

1.78

2.11

2.2

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

160

1.76

2.09

1.3

1.80

1.12

nmol/l

1.39

121

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.01

2.07

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.01

2.07

1.2

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

117

1.89

2.06

2.4

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

103

1.95

2.05

1.4

2.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.00

2.04

4.3

6.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

261

0.46

2.03

1.3

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

2.03

0.0

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

2.03

0.0

3.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

260

0.46

2.02

1.3

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

3.08

2.01

1.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

259

0.46

2.00

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

259

0.46

2.00

1.3

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

443

1.43

1.99

1.5

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.29

1.97

1.4

1.1

0.64

0.72

umol/24h

—

(1761482) Bacteria [#/volume] in Urine by Culture

112

866

1.30

1.96

5.8

4.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.03

1.95

3.4

6.6

60.00

72.38

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.55

1.94

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

142

1.77

1.92

1.3

1.4

59.10

63.46

0.26

114

(3017446) Testosterone [Moles/volume] in Serum or Plasma

291

2500

1.18

1.92

2.6

2.2

12.33

12.93

nmol/l

0.57

252

2223

(3014051) Protein [Presence] in Urine by Test strip

101

775

1.31

1.88

3.0

2.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

279

0.50

1.88

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.87

1.86

3.9

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.87

1.86

3.9

2.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.98

1.84

1.1

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.21

1.84

1.0

1.1

—

6.94

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

261

1.54

1.84

2.1

2.3

—

(40768800) Prostate Pathology biopsy report

764

0.70

1.83

1.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

115

1.83

1.82

2.4

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

115

1.83

1.82

2.4

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.13

1.81

1.1

—

(3016228) CD19 cells/100 cells in Blood

108

1.86

1.81

1.4

2.0

8.65

8.84

0.03

103

(3016750) Collection duration of Urine

184

1.64

1.78

2.3

2.0

511.76

489.48

min

0.60

131

(3005570) Glucose [Moles/volume] in Urine

304

1.49

1.77

1.9

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

363

3196

1.15

1.76

3.1

4.0

14.25

21.99

ug/l

0.72

283

2646

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

240

1.55

1.75

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

185

1.63

1.75

2.1

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.03

1.74

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

170

1.65

1.73

1.4

1.6

—

(3026480) Teichoate Ab [Titer] in Serum

2.67

1.72

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.92

1.72

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

776

0.72

1.71

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

250

1.53

1.70

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

171

1.64

1.70

1.4

1.6

—

(3042733) HLA Ab [Presence] in Serum

1.91

1.69

5.2

4.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

220

1868

1.19

1.69

2.1

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

215

0.46

1.69

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

1.58

1.68

1.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

693

1.31

1.67

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

638

6954

0.90

1.66

2.7

3.1

0.70

0.79

ug/l

1.99

441

4715

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.16

1.66

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

213

0.47

1.65

1.4

—

(3021788) Differential panel - Synovial fluid

538

1.35

1.64

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

243

2814

0.85

1.62

1.5

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.95

1.59

6.2

6.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.33

1.58

2.7

4.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

114

1.76

1.56

1.6

1.7

5.49

9.47

nmol/l

0.37

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.89

1.54

1.3

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.89

1.54

3.8

2.5

—

(3000330) Specific gravity of Urine by Test strip

188

1591

1.19

1.53

4.8

3.6

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

3.34

1.52

2.0

2.1

2.90

1.53

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

282

1.46

1.52

1.7

1.6

—

(3035880) pH of Pleural fluid

201

1.55

1.51

1.4

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.50

2.8

1.6

—

(3004775) Volume in Urine collected for unspecified duration

258

1.48

1.50

2.2

755.00

632.75

0.99

161

(3022621) pH of Urine by Test strip

227

1958

1.17

1.48

3.2

—

(3049717) Cytology report of Urine Cyto stain

156

1304

1.21

1.46

2.1

2.7

—

(3008037) Lactate [Moles/volume] in Venous blood

771

1.27

1.45

4.9

3.3

1.87

1.66

mmol/l

0.86

751

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.12

1.44

3.2

1.6

—

(3014891) Appearance of Pleural fluid

2.12

1.44

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

3.13

1.44

1.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

386

0.65

1.39

3.9

3.8

40.56

36.43

u/ml

0.09

375

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.42

1.39

1.0

1.1

—

22.00

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.90

1.39

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

145

1211

1.21

1.38

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.08

1.38

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

206

1.51

1.37

1.5

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.80

1.37

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.94

1.36

1.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

443

1.34

1.35

1.2

1.1

17.67

78.93

iu/ml

1.29

(3008401) Mugwort IgE Ab [Units/volume] in Serum

333

0.63

1.33

1.0

1.1

0.22

1.21

u/ml

1.83

138

(3001186) Copper [Moles/volume] in Serum or Plasma

1.97

1.32

1.0

1.1

15.70

16.61

umol/l

0.27

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

176

1.54

1.31

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

219

0.55

1.29

1.4

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.40

1.24

1.2

2.8

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.40

1.24

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

339

0.65

1.24

1.0

1.1

2.33

5.55

u/ml

1.71

170

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

110

906

1.22

1.24

1.8

38.17

40.54

nmol/l

0.44

104

874

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.97

1.22

1.2

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.80

1.21

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.80

1.21

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.31

1.18

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

668

1.25

1.17

2.0

1.9

216.49

204.31

pmol/l

0.26

630

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1265

12109

1.07

1.14

4.4

5.0

3.60

ug/l

0.00

1100

10820

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

167

1.50

1.12

1.8

2.8

43.37

38.86

0.82

(3033705) Calcium.ionized [Moles/volume] in Venous blood

432

1.30

1.11

3.8

2.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

566

1.26

1.10

1.2

1.3

310.00

219.12

miu/ml

0.67

232

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

169

1.48

1.07

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

169

1.48

1.07

1.3

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

686

1.23

1.06

1.1

12.07

7.49

u/ml

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.12

1.05

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.79

1.04

4.4

7.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.89

1.01

1.1

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

107

0.47

1.01

1.4

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.65

1.00

3.3

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

573

0.77

0.99

1.3

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

107

1.59

0.99

3.1

2.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.97

0.0

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

381

1.29

0.95

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

1214

0.84

0.94

1.1

1.0

—

(3002619) Bacteria identified in Specimen by Culture

1.77

0.94

1.4

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

537

1.23

0.90

1.2

24.07

44.60

u/l

1.90

463

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.07

0.89

33.8

8.0

—

(1002224) Polysomnography panel

958

0.83

0.89

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

152

0.59

0.88

5.8

6.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

439

4083

1.09

0.88

1.3

1.2

7.51

14.64

u/ml

1.25

148

1531

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

377

1.28

0.88

1.1

1.2

3.55

3.19

u/ml

0.06

124

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.65

0.88

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

120

1.50

0.85

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

215

0.65

0.84

1.0

0.67

0.36

u/ml

—

(3015183) Erythrocyte sedimentation rate

114

0.53

0.82

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

301

1.30

0.82

1.3

166347.33

125259.03

e6/l

0.15

207

(3023487) Leukocytes [#/volume] in Peritoneal fluid

105

1.53

0.81

3.0

2.5

1154.00

745.14

e6/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

365

1.26

0.79

1.3

1.5

55.69

61.91

0.41

230

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

463

0.78

1.3

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.3

—

1.40

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.52

0.78

1.2

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

676

1.19

0.77

1.9

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

367

1.26

0.77

1.1

1.2

3.15

4.77

u/ml

0.88

165

(3024263) Appearance of Synovial fluid

174

1.38

0.76

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.77

0.76

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

929

9673

0.95

0.76

3.7

4.3

22.17

21.91

0.17

450

4774

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

368

1.25

0.75

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

381

0.76

0.75

1.1

1.17

2.04

u/ml

0.84

192

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

175

1.37

0.74

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.64

0.73

2.7

2.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.75

0.71

1.9

1.4

43.29

43.98

umol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.58

0.71

1.0

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.92

0.70

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.53

0.69

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

204

1.33

0.68

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

833

0.85

0.68

1.8

1.7

5.49

4.18

mg/l

0.24

616

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

772

1.16

0.66

2.4

2.2

249.51

96.42

ug/min

1.50

462

(3035320) C reactive protein [Mass/volume] in Body fluid

197

1.32

0.65

2.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.59

0.65

1.0

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.73

0.64

2.8

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

181

1.33

0.63

1.3

2.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.52

0.62

2.1

2.3

—

(4212803) Bone marrow aspirate examination

1.67

0.61

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.60

0.0

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

139

1.37

0.60

1.1

1.2

1.12

1.06

ratio

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.58

0.0

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.51

0.58

4.1

7.1

—

(40768795) Lymph node Pathology biopsy report

265

0.75

0.58

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.72

0.57

1.2

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.48

0.57

1.5

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.48

0.57

1.2

1.6

—

(3002256) Pathology report gross observation

351

3725

0.94

0.56

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

251

0.76

0.55

1.0

12.24

3.00

u/ml

0.50

118

(3045142) Bone marrow Pathology biopsy report

340

0.79

0.55

1.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

1.46

0.54

3.2

2.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.54

0.53

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

158

1725

0.91

0.53

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

326

0.80

0.51

1.0

1.1

1.34

2.83

u/ml

—

131

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.50

0.51

16.5

13.6

3.32

5.82

mmol/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

206

1.26

0.51

2.3

1.6

71.23

87.94

umol/l

1.93

206

(3009871) Measles virus Ab [Titer] in Serum

1.47

0.50

1.4

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.39

0.50

1.4

1.5

—

(3018133) Calcium [Moles/volume] in Urine

1.46

0.50

3.0

2.5

1.75

2.93

mmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

312

0.80

0.48

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

110

1.37

0.48

5.7

3.9

58.67

56.30

0.15

105

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.40

0.48

2.8

2.3

887.17

21294.12

e6/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.45

0.48

1.5

1.3

9.69

9.05

ug/l

0.17

(40768804) Tissue Pathology biopsy report

1142

11134

1.04

0.47

2.1

2.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

345

1.19

0.47

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

300

0.80

0.47

1.0

1.1

4.37

1.64

u/ml

0.36

153

(40765089) Chromosome analysis panel - Blood by G-banded

1.49

0.47

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

102

1.37

0.47

1.4

1.2

45.33

38.68

g/l

—

(3034426) Prothrombin time (PT)

1.41

0.46

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

258

2737

0.94

0.44

1.5

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

293

1.20

0.44

1.3

1.4

13.90

27.25

2.38

179

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

130

1.31

0.43

1.1

1.0

9.39

12.07

iu/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

174

0.75

0.43

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.61

0.43

1.4

1.2

1.58

1.87

umol/24h

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.61

0.43

1.4

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.56

0.42

9.6

4.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.19

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.09

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.11

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.43

0.39

1.6

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.43

0.39

1.6

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.43

0.39

1.6

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.39

1.1

120.30

101.52

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

252

1.19

0.37

2.0

2.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.35

0.37

1.0

1.1

70.48

76.41

ug/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

191

0.78

0.36

1.1

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.35

1.3

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

171

1.23

0.35

2.4

1.5

1.01

0.95

g/l

0.31

171

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.37

0.34

2.3

2.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

181

1.22

0.34

1.3

0.59

1.40

u/ml

0.69

106

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

163

1.23

0.34

4.4

3.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

321

1.15

0.33

1.1

—

(3004451) EKG impression Narrative

164

1.22

0.32

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.28

0.32

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

154

0.78

0.32

1.1

—

(40765096) Chromosome analysis panel by Banding

100

0.70

0.30

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

315

1.14

0.30

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

278

1.15

0.29

1.2

359.90

343.13

nmol/l

0.18

230

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

176

1.19

0.28

2.9

3.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

103

1.26

0.28

1.1

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.30

0.28

1.1

1.3

30.00

28.95

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.25

0.27

1.4

—

(3020491) Glucose [Moles/volume] in Blood

226

0.84

0.27

1.4

2.5

6.28

6.99

mmol/l

1.08

148

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

715

7308

0.97

0.26

1.7

1.6

1.54

1.37

mmol/l

3.64

600

6089

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.70

0.26

3.0

3.1

—

59.09

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

246

0.85

0.26

1.3

1.4

98.84

207.41

pmol/l

1.94

246

(3048879) Bone marrow aspiration report

1.25

0.24

1.9

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

657

1.08

0.24

2.3

3.4

476.79

921.43

u/ml

0.42

603

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

407

1.11

0.24

3.1

2.6

5.26

778.56

u/ml

0.64

398

(3024471) HLA-A [Type]

1.27

0.24

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

233

0.86

0.23

1.0

2.04

3.47

u/ml

0.55

(40758292) HTLV I+II Ab panel - Serum

1.28

0.23

1.2

1.4

—

(3003694) ABO and Rh group [Type] in Blood

755

7411

1.02

0.22

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

337

0.89

0.22

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

326

0.89

0.22

1.9

3.4

3.80

22.22

nmol/l

0.57

321

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

363

3733

0.97

0.21

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.12

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

536

1.08

0.21

1.2

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

188

0.85

0.21

1.1

1.9

8.65

10.89

umol/l

0.23

128

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.10

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(4034850) Laboratory test

922

0.94

0.19

15.5

10.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2705

27178

0.98

0.19

4.7

4.5

1.38

1.42

mmol/l

5.91

2379

24750

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

137

1.17

0.18

1.1

1.0

—

(3008898) HLA-B27 [Presence]

754

1.06

0.18

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.17

0.17

1.0

1.3

—

118.60

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

692

0.94

0.17

4.0

3.6

26.71

29.38

mg/l

0.23

438

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

108

1131

0.95

0.17

2.6

3.3

99.63

4622.50

u/ml

1.14

969

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2616

26274

0.98

0.16

4.3

4.0

1.43

1.31

mmol/l

10.01

2294

23720

(3002523) Influenza virus A Ag [Presence] in Specimen

338

0.92

0.15

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

482

0.93

0.15

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

284

1.09

0.15

2.3

3.1

13.36

36.21

mg/l

1.69

221

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

192

0.88

0.14

1.1

1.2

—

(3000492) Spirometry study

253

2594

0.97

0.14

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

851

1.05

0.14

2.0

—

(21494434) Karyotype in Bone marrow

284

0.91

0.13

1.1

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

228

1.10

0.13

1.5

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

232

0.90

0.13

1.2

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

142

1.13

0.12

1.1

1.2

—

(3024932) HLA-DR beta [Type]

1.18

0.12

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

191

1.10

0.11

1.8

2.1

2.32

1.96

ug/l

0.35

163

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.16

0.11

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

167

0.90

0.10

1.4

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.11

0.09

1.0

1.4

120.00

106.03

—

(3006462) Nitrate [Presence] in Urine

135

1.11

0.09

4.7

3.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

0.90

0.09

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.09

0.08

1.5

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

134

0.90

0.08

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

834

1.03

0.08

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2813

28072

1.01

0.08

5.2

5.0

2.53

2.66

mmol/l

11.09

2489

25596

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.80

0.07

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.05

0.07

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.84

0.06

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

138

1.09

0.06

1.7

1.3

1.54

g/l

0.02

138

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

109

1.10

0.06

1.2

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

276

1.05

0.06

1.4

—

(4281824) Cell count and differential, peritoneal fluid

241

0.95

0.04

1.5

1.2

—

(40768793) Breast Pathology biopsy report

517

1.03

0.04

1.4

1.3

—

(40768441) Liver Pathology biopsy report

190

1.05

0.04

1.9

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

201

1.05

0.03

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2740

27413

1.00

0.01

4.7

4.5

4.39

4.53

mmol/l

10.20

2428

25139

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

166

0.96

0.00

1.9

2.1

131.17

299.62

ug/min

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

0.98

0.00

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.5

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

3.56

—

(3051101) Glucose [Moles/volume] in Cord blood

1.00

-0.00

5.7

6.9

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

7.06

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.62

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

8.0

—

74.80

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

190

1.00

-0.00

1.7

1.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1740.00

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MYOPOTHUNS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MYOPOTHUNS	2.128 [1.88, 2.4]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.218

During the follow-up period (1.1.1998 — 31.12.2019), 4593 out of 11033 females with G6_MYOPOTHUNS died.

Males

Parameter	HR [95% CI]	p-value
G6_MYOPOTHUNS	3.28 [2.85, 3.77]	< 0.001
Birth year	0.98 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 6141 out of 14096 males with G6_MYOPOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MYOPOTHUNS.

N-year risk	Females	Males
1	0.162%	0.382%
5	1.126%	2.7%
10	2.76%	7.574%
15	5.343%	13.817%
20	10.187%	21.645%

Relationships between endpoints

↥

Index endpoint: G6_MYOPOTHUNS – Other and unspecified myopathies

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified myopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints